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Specific immunization with live attenuated trypanosomes
and stimulation of non-specific resistance by viable
Mycobacterium tuberculosis strain BCG were used to examine
mechanisms of induced immunity against Chagas' disease
in mice. In addition, the effects of acute infection
on the immune response of mice to antigens unrelated
to the trypanosomes were observed.
Resistance to T. cruzi in mice appears to be cellmediated and to require specific activation of the immune
system. BCG alone did not protect against acute infection
but live attenuated trypanosomes did if given at least
12-14 days in advance of challenge. Killed trypanosomes
were not protective. Administration of silica, a macro
phage toxin, prior to challenge exacerbated infection.
Activation of the immune system with BCG actually
interfered with the induction of specific resistance
by attenuated trypanosomes.
Mice lost their ability to mount an immune response to
other antigens during the period of acute infection.
Suppression of humoral and cellular responses occurred
during the stages of marked parasitemia. Infected mice
unable to respond to oxazolone could confer sensitivity
to this substance via spleen cell transfer. The ability
of infected mice to respond to oxazolone was significantly
improved when they received syngeneic macrophages at the
time of skin test.
Mice became increasingly susceptible to bacterial
endotoxin as the infection progressed, also suggesting
impairment of their immune response.
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Chapter 1
INTRODUCTION
Classification of Trypanosoma cruzi
Hoare, 1966
Phylum PROTOZOA Goldfuss, 1818; emend. Siebold, 1845

Subphylum SARCOMASTIGOPHORA Honigberg and Balamuth, 1963
Superclass MASTIGOPHORA Diesing, 1866
Class ZOOMASTIGOPHORMA Calkins, 1909
Order KINETOPLASTIDA Honigberg, 1963
Suborder TRYPANOSOMATINA Kent, 1880
Family TRYPANOSOMATIDAE Doflein, 1901;
emend. Grobben, 1905
Genus TRYPANOSOMA Gruby, 1843
Species CRUZI Chagas, 1909
General
Chagas' disease, or American trypanosomiasis, is the
result of infection with Trypanosoma (Schizotrypanum) cruzi,
a protozoan parasite of man and many other mammals.

It is

an extremely important public health problem in many IberoAmerican countries.

The disease is widely distributed,

occurring in portions of the southern United States and most
of the South American countries.

An estimated seven million

persons are believed to harbor the parasite (41) and the
mortality rate is high, especially among young children.
is most often a severe chronic infection leading to
1

It
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debilitation of the victim through a variety of path
ological changes.
The disease is transmitted by many species of reduviid
bugs (subfamily Triatominae), also known as cone-nosed or
kissing bugs.

In Latin America, they are known popularly

as barbeiros, hitas, pitos, or vinchucas.

These blood

sucking insects feed at night and defecate immediately
after feeding.

The excreta contains the infective stages

of the parasite, which have completed the final stages of
development in the digestive tract of the bug.

Contamina

tion of the mucous membrane of the eye or of the wound
made by the bite leads to infection.

This method of

transmission is referred to as posterior station.

The main

reservoirs of the disease appear to be armadillos and
opossums, but many other terrestrial mammals are infected.
Other means by which humans may become infected include
blood transfusion and transplacental passage.
Trypanosoma cruzi has two main stages in its life
cycle.

One takes place in man or a reservoir host, and

the other in the insect vector.

The parasite is pleo

morphic, occurring in different forms during the course
of its life cycle.

The insect ingests the trypanosomes

with a blood meal, and the insect forms develop to the
infective forms found in the feces.

The parasites, having

gained entrance into a suitable host, multiply rapidly at
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the site of infection and a local inflammatory reaction
ensues.

This consists of cellular infiltration character

istic of a local inflammation, with both polymorphonuclear
and mononuclear phagocytes present.
nodes become enlarged.

The regional lymph

After a brief incubation period the

organism enters the blood stream and initiates the acute
phase of Chagas' disease.

The organism will not divide

in the blood stream, but does so only within cells which
either engulf the parasite or are invaded by the organism.
Some strains have greater affinity for muscle tissue,
especially cardiac, while others preferentially invade
nervous or

reticuloendothelial tissue.

Most strains

divide readily within host macrophages (6, 91). Char
acteristic features of this phase of Chagas' disease in
clude splenomegaly and hepatomegaly, generalized adeno
pathy, and fever.

Parasites are readily isolated from the

blood during the acute phase.

If the host survives, the

chronic phase is initiated, which is characterized by few
circulating trypanosomes and progressive tissue destruc
tion by the intracellular forms.

The chronic phase may

extend for a period of many years but spontaneous recovery
may occur.

Death often results from severe damage to the

heart, or from the destruction of nerve plexi responsible
for maintaining muscle tone in the alimentary canal lead
ing to megacolon or megaesophagus.

When few circulating

4

parasites are present, diagnosis may be made by hemoculture
or by xenodiagnosis.

The latter is a procedure utilizing

a non-infected vector which is allowed to feed on the
patient and is subsequently examined for the presence of
parasites.

Trypanosoma cruzi is the only major pathogen

of the Stercoraria group of trypanosomes.
History
Accounts of a disease, "Bicho", peculiar to the area
of the natural distribution of the reduviid bugs began to
appear in American chronicles as early as the 16th century.
The disease was described as having a long and chronic
course, with a characteristic feature of rectal distension
(34).

Infestation of the diseased rectum by worms led the

early observers to believe the disease was caused by hel
minthic infection, and they named it "Mai de Culo" in
Spanish, or "Maculo" in Portuguese.
disease of the colon.

This means simply

Later reports referred to "Mai de

Engasgo", or megaesophagus, as being a serious disease in
Brasil.

A common treatment was to apply juice from the

tobacco leaf to the affected area.
Observations of the reduviid vectors were recorded
long before the identification of the parasite.

A passage

from Charles Darwin (1809 - 1882) describing his encounter
with the insects appeared in the "Journal of researches
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into... various countries visited by H. M. S. Beagle",
London, 1839 (after Guerra, 1970).
(1839 ed., pp. 403-404)

"... At night I experienced

an attack (for it deserves no less a name) of the 'Benchuca'
(species of Reduvius) the great black bug of the Pampas.
It is most disgusting to feel soft wingless insects, about
one inch long, crawling over one's body.

Before sucking

they are quite thin, but afterwards become round and bloated
with blood, and in this state they are easily crushed.
They are also found in the northern parts of Chile and in
Peru.

One which I caught at Iquiques was very empty. When

placed on the table, and though surrounded by people, if a
finger was presented, the bold insect would immediately
draw its sucker, make a charge, and if allowed, draw blood.
No pain was caused by the wound.

It was curious to watch

its body during the act of sucking, as it changed in less
than ten minutes, from being as flat as a wafer to a globu
lar form.

This one feast, for which the 'Benchuca* was

indebted to one of the officers, kept it fat during four
whole months; but, after the first fortnight, the insect
was quite ready to have another suck."

This account is

especially interesting, for it is generally agreed that
Darwin contracted Chagas' disease on this expedition, and
suffered from the infection, until his death some forty
years later (57).

6

In 1907, Carlos Chagas, a young medical officer, was
assigned to investigate measures to be taken to safeguard
the health of railroad workers in the Minas Gérais state
in the United States of Brasil.
area was malaria.

The main concern in the

While investigating local insects, he

noticed flagellated protozoa in the hindgut of the conenosed bugs.

It should be remembered that this was a time

of great interest in insects and their role as vectors,
for in 1893, Theobald Smith had associated a tick with
Texas Cattle Fever (85).

Chagas sent specimens to his

supervisor, Oswaldo Cruz in Rio de Janeiro.

Shortly after

his initial findings of the organisms in bugs, Chagas
found them in the blood of monkeys and in a small girl
suffering from an unknown illness.

(It is interesting to

note that this girl was found to be harboring the parasite
some sixty years after being examined by Chagas).

These

investigations were followed by numerous findings of the
parasite in human patients, and it was soon associated with
a disease known to be prevalent in that area.

This is an

unique example of the identification of an etiological
agent before that agent was associated with a disease.
Chagas went on to describe the life cycle of the
parasite (11, 12) but mistakingly thought the organism
was passed to mammals directly through the bite of the
bug (anterior station transmission), and that multiplication

7

occurred in the mammal by a form of schizogony.
the misnomer Schizotrypanum cruzi.

Hence

These mistakes con

cerning the transmission and life cycle of T. cruzi were
corrected by Brumpt (9).
Immunity
The course of infection with T. cruzi is influenced
by a number of factors.

The numerous strains capable of

causing infection vary greatly in their virulence for
different hosts.

This variation is affected by their

histotropism, as well as a variety of host factors.

Among

the most virulent strains is the Tulahuen, a reticulotropic strain first isolated in Chile from a human patient.
This organism shows a special affinity for host macro
phages (90).

As with most virulent strains, the Tulahuen

shows a preference for a certain tissue but is capable of
invading and dividing in others.
Among the host factors influencing the course of the
disease are age and sex.

In general, young males are most

susceptible to infections.

The mortality rate is especial

ly high in children.
Natural immunity to Chagas' disease is not uncommon,
as evident from the large number of asymptomatic carriers.
Both humoral and cellular immune responses occur in T. cruzi
infection (64, 65, 72).

The acute phase, characterized by

a progressive rise in parasitemia can be established (61).

8

Both IgM and IgG classes of antibody are present during
the acute stage (28, 99).
The role of these antibodies in immunity is not well
established.

Conference of protection by passive transfer

of immune serum has been generally unsuccessful (19, 38).
Complement-mediated lysis of culture forms occurs

vitro,

and complement depletion in mice has been reported to
exacerbate infection (73).

Some workers have reported

passive transfer of protection with immune serum (46), but
with most strains of high virulence this is not possible.
The value of antibodies in protection was supported by
the observation (52) that mother rats could transfer immu
nity to their offspring, but in human cases, infants with
high antibody titers at birth often have severe parasitemia.
Much of the apparent contradiction of the results concern
ing protection and antibody in Chagas' disease may be due
to differences in strains used, and in the interpretation
of results, since much of the work was done before many of
the immunological processes were understood.
To support the view that antibodies are not directly
responsible for the destruction of T. cruzi in vivo, Pizzi
put forth the following arguments (41): a) immunized rats
can be shown to have high antibody titers but little or no
protection, b) the serum of immune animals has no effect on
virulent trypanosomes

vitro, c) administration of
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hyperimmune serum to non-immune animals fails to protect
them against infection, d) splenectomy does not alter the
course of infection, and e) newborns with high titers of
specific antibody may be born with acute parasitemia.
The importance of cell-mediated immunity in Chagas'
disease is well established.

Delayed skin reactions can

be demonstrated in immunized and chronically infected
individuals (95), and passive transfer of sensitivity to
T. cruzi antigens can be made

using lymphocytes from

sensitized donors (93). ^ vitro correlates of cellular
immunity, such as blast cell transformation and inhibition
of macrophage migration have also been observed (79, 80,
81, 95, 107).
Immune protection against lethal challenge involves
cellular immunity, as shown by the passive transfer of
protection with spleen cells from infected animals (53, 76).
Animals that have been thymectomized or treated with antithymocyte serum prior to challenge with virulent T. cruzi
develop higher parasitemias and die more rapidly than do
normal infected animals (75, 78).
Animals with acquired immunity mobilize inflammatory
macrophages when challenged with T. cruzi as do non-immune
animals, but they do so more rapidly and with higher
numbers (26).

Phagocytosis appears to be very important

in defense against T. cruzi infection.

Some workers (47)
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have reported enhancement of infection when experimental
animals were pretreated with silica particles to destroy
phagocytic cells.

Correspondingly, non-specific stimu

lation of the reticuloendothelial system with diethylstilbesterol or complete Freund's adjuvant reportedly
enhances resistance when used in the presence of specific
antigen (3, 49).

Non-specific activation of the reticulo

endothelial system with BCG is not a useful method to
protect against virulent challenge, however.

Although one

group of investigators has reported achieving non-specific
resistance using viable BCG (69), the great majority of
attempts to immunize with BCG have been unsuccessful
(4 2, 53).
The fact that virulent T. cruzi can multiply within
macrophages suggests that they are generally resistant to
phagocytic process of these cells.

Some

vivo studies

have shown the parasites are destroyed in macrophages of
immune animals, but survive and multiply in normal macro
phages (90).

This is consistent with the idea of the

importance of phagocytosis in immune protection against
Chagas' disease.

However, inconsistencies arise from

studies using BCG-activated macrophages.

Hoff (42) has

shown that macrophages from BCG-immunized animals were
able to limit parasite multiplication and to resist de
struction better than normal macrophages when cultured
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with virulent T. cruzi in vitro »

In fact, the macro

phages from BCG-immunized mice were as resistant as those
from mice specifically immunized with live avirulent
T. cruzi.

Interestingly, when either of the groups of

activated macrophages were incubated with immune serum,
their ability to destroy the parasites was significantly
increased, strongly suggesting an important role for cytophilic antibody.

Immune serum did not alter the resistance

of normal macrophages to T. cruzi.

Although BCG-activated

macrophages were more resistant than normal ones ^ vitro,
BCG-immunized mice were not protected against lethal
challenge, even when the parasites were first incubated
with immune serum.
Infection alone, without prior immunization, appears
to activate the host reticuloendothelial system.

Macro

phages from infected animals spread more on glass than do
normal cells, and the clearance of colloidal carbon parti
cles from the bloodstream is more rapid in infected than
in normal mice (15).
Immunization
Further implicating the importance of cell-mediated
immunity in Chagas' disease is the proven superiority of
live vaccines to produce protection against virulent in
fection (60, 106).

Animals that survive acute infection

12

are usually resistant to subsequent infection (19, 105).
In some cases, this is not a sterile immunity, but relies
on the presence of parasites in the host.

This condition

is known as premunition.
Protection is often produced experimentally with live
attenuated trypanosomes.

Repeated passage in culture

media is a useful way to produce organisms of lowered
virulence (62).

X-irradiated organisms may also be used

for immunization.

The use of live vaccines for prevention

of Chagas' disease in man is not advocated at this time
due to the limited information available regarding possible
reversion of attenuated organisms to the virulent state and
the potential of producing chronic infection by such vaccines.
Killed organisms are far less effective immunizing
agents.

In a few instances, incorporation of a killed

vaccine with an adjuvant provided some degree of resistance
(44).

Methods that kill the organism but leave it intact

are desirable.

Fernandes et al^. (22) were able to protect

animals against lethal challenge by first incubating the
organisms with actinomycin D.

This procedure left the

organism motile, but unable to divide due to blockage of
nucleic acid synthesis.

Recently, culture forms killed

with a mild solution of sodium perchlorate have proven
effective for immunization of experimental animals (49).
To achieve good protection with killed organisms, multiple
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doses are usually necessary (106).

Animals effectively

immunized, especially with organisms of low virulence,
typically demonstrate good cell-mediated responses to
T. cruzi antigen (27, 79).
All of the reticuloendothelial organs may undergo
change during infection, due to the presence of large
numbers of organisms in macrophages.

The most dramatic

changes occur in the spleen and lymph nodes.

In the

spleen, hyperplastic and degenerative changes occur
concommitantly.

The hyperplasia predominates initially,

and is followed by degeneration (90). In general, an
overall reduction of lymphocytes is seen in spleens of
severely infected hosts.

Macrophages appear activated,

and are often engorged with parasites and cellular debris.
As the infection progresses, an increase in the ratio of
large lymphocytes to small is noted.
Lymphocyte depletion is also noted in certain areas
of the lymph node, along with mobilization of reticular
cells.

Whether or not the overall lymphocyte population

of the nodes declines is doubtful, for intense mitotic
activity takes place until just before death or recovery
from the acute phase.

This activity predominates through

out the node, and especially in the B-lymphocyte-rich
cortical areas.
In the liver of an infected animal, Kupffer cells
are often seen to contain many parasites.

Acute and
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chronic hepatitis develops, with local inflammatory lésions
throughout.

Although often filled with parasites, the

Kupffer cells apparently do not lose their ability to
phagocytose other particles as demonstrated by the increased
rate of carbon clearance in infected animals.
Tissue destruction and inflammation occurs in many
other areas; particularly in muscle, nervous, and gonad
tissue.

The damage is generally caused by invasion and

multiplication by the parasite, although the possibility
of damage from toxins may exist {25, 51).

Evidence for

toxic damage stems from observations of destruction of
uninfected cells.

Furthermore, a trypanosomal toxin has

been postulated to explain inhibitory effects on certain
malignancies seen in animals with T. cruzi infection
(36, 37).

An extract from cultured T. cruzi is sold

commercially in Europe under the trade name "Trypanosa"
for use as an antitumor agent.
Some workers suggest that a state of allergy is
produced during infection by sensitization to antigens
released by degenerated parasites.

Muniz and Azevado

(63) were able to produce lesions of myocarditis in
monkeys indistinguishable from those seen in Chagas'
disease

by the injection of dead antigens of T. cruzi.

Some of the pathological changes are due to destruction
of neurons throughout the peripheral nervous system.
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Allergie type reactions may have a role in this aspect
of the pathology.
Immunosuppression in Protozoal Infections
An interesting phenomenon associated with certain
protozoal infections is the suppressive effect these
infections have on the ability of the host to respond to
other antigens.

This has been observed in malaria,

leishmaniasis, toxoplasmosis, African trypanosomiasis,
and Chagas' disease (1, 7, 14, 15, 16, 17, 29, 30, 31,
32, 39, 66, 77, 98).

Affects on both humoral and cellular

immunity have been noted, though not always in the same
disease.

The mechanisms involved are not understood,

and appear to be varied and complex.

It is probable

that active infection is necessary for the immunosuppress
ive effect to occur (59, 109).
There is evidence for direct lymphocyte involvement,
since histological aberrations of the spleen and lymph
nodes appear in animals with malaria, toxoplasmosis,
Chagas' disease, and African trypanosomiasis (30, 39, 59,
90).

Many of the parasites involved with immunosuppression

are harbored within blood cells (Toxoplasma, T. cruzi,
Leishmania, Plasmodium), but others are not (African
trypanosomes).

Many differences in the host-parasite

relationships involved in these diseases make it difficult
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to postulate a common mechanism for immunosuppression.
Possible mechanisms at work in immunosuppression associ
ated with protozoal infection will be discussed later.
Interest in this aspect of the infectious process lies
in a better understanding of the immune system, with
special reference to cell cooperation.

Clinically,

immunosuppressive effects stemming from such infections
could predispose patients to other disease.
Suppression of cell-mediated immunity may be dir
ected against the afferent or efferent arm of the response.
Delayed hypersensitivity reactions may be considered to
occur in two stages:

the induction of the response and

the expression or manifestation of the response.

During

the inductive phase, T-lymphocytes become "primed" by
the antigen and are stimulated to begin producing clones.
After sufficient time has elapsed for significant numbers
of these cells to be produced, the host is able to respond
to eliciting doses of the sensitizing substance, and
thus to express delayed hypersensitivity.

This stage is

characterized by a visible reaction at the site of
injection of specific antigen and the typical cells ob
served in histological preparations of the lesion.
When oxazolone, a chemical contact sensitizing agent,
is applied to the skin, large pyroninophilic cells, termed
immunoblasts, appear in the lymph node draining the site
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of application.

Expression of the response involves

induration and erythema at the site of skin test, and an
abundance of lymphocytes and macrophages in the lesion.
There is typically a relative paucity of polymorpho
nuclear leukocytes (97).
Statement of Problem
This research was designed.to examine:

1) proce

dures for immunization against Trypanosoma cruzi and
2) the effects of acute infection with this parasite on
the immune system of the host.

Chapter 2
MATERIALS AND METHODS
Animals
Conventional outbred male Swiss mice, weighing
30-40 g were used in most experiments.

In the passive

transfer studies, inbred C57B1/10 mice, adult males,
were used.

All mice were obtained from the Rocky

Mountain Laboratory in Hamilton, Montana, housed in
plastic cages, and given Purina Lab Chow and water
ad lib.
Parasites
Blood and culture forms of the Tulahûen strain of
Trypanosoma cruzi were obtained from Dr. Robert G. Yaeger
(Dept. of Tropical Medicine, Parasitology Division, Tulane
University, New Orleans, La.).
Blood forms were maintained by weekly passage of
whole blood from infected to normal mice.

Culture forms

were maintained in the dialysate media of Nakamura (1967).
These organisms have been passed in culture more than
300 times.

Dialysate media was chosen to minimize foreign

proteins in the cultures.

Culture forms were used for

immunization and blood forms for infecting mice.
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Media
Powdered MEM (Eagle) with Earle's Salts, L-glutamine,
and non-essential amino acids was purchased from GIBCO
(Santa Clara, Ca.) and was reconstituted to 90% of its
final volume with triple distilled water.

Streptomycin

sulfate and penicillin G were added during preparation to
final concentrations of 100 pg/ml and 100 U/ml respectively.
The pH was adjusted to 7.3 with NaOH.

The media was

filter-sterilized before use.
Determination of the Lethal Dose-fifty (LD^Q)
Determination of the LD^^ for the Tulahûen strain in
Swiss and C57B1/10 mice was performed by challenging mice
with different numbers of blood forms obtained from
infected mice.

Blood was drawn into a heparinized syringe

by severing the brachial artery of an etherized mouse in
which the parasitemia was high.

Approximately 1.0 ml of

blood was obtained in this manner from a 30 g mouse.

The

blood was diluted with sterile Locke's solution and the
trypanosomes were counted with a hemocytometer.

The

parasite suspension was adjusted to concentrations ranging
from 5 X 10^ to 1 x 10^ parasites/ml and 0.2 ml of each
concentration was injected into groups of 8 mice each.
The Swiss mice were injected with various concentrations of
parasites by intravenous (iv) or intraperitoneal (ip)
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routes.

Deaths were recorded on a daily basis.

Sur

vivors were killed after forty days.
Immunization Studies
Adult male conventional Swiss mice were used in this
and all subsequent experiments with the exception of the
cell transfer studies.
BCG vaccine
Attenuated Mycobacterium bovis, or BCG (bacille
Calmette-Guérin), was obtained from stock maintained in
the Stella Duncan Institute.

Stock cultures were diluted

with Dubos broth to an optical density of 200 ("Klett 200")
on a Klett-Summerson photoelectric colorimeter equipped
with a blue filter (Klett-Summerson no. 42, spectral range
400-465nm).

These were stored at -70 C and prepared for

use as follows:

After thawing, the stock was diluted to a

"Klett 100" suspension by adding an equal volume of Dubos
broth.

This was inoculated ip into mice in 0.2 ml volumes.

To determine the number of colony-forming units (CPU) of
BCG administered, 3 0.1 ml volumes of 10~^, 10~^, 10~^
dilutions were plated on duplicate Dubos agar plates.

The

plates were sealed in plastic bags and incubated at 37 C
for 28 days.

The visible colonies were counted, making it

possible to calculate the number of viable BCG organisms/
dose.

This number was found to be 5 x 10^ - 10 x 10^.

21

T. cruzi vaccine
To prepare trypanosomes for use in immunization,
dialysate media was inoculated with culture forms of
T. cruzi and incubated at 28 C for 14-16 days.

This was

sufficient time to achieve prolific growth in media
seeded with approximately 5 x 10^ organisms/ml.

After

incubation, cultures were centrifuged at 5,000 x g for
10 minutes and the pellet was resuspended in sterile
Locke's solution.

The parasites were washed 3 times and

adjusted to a concentration of approximately 1 x 10^/ml.
Mice injected ip with 0.02 ml of this suspension of live
trypanosomes 14 and 7 days before challenge with virulent
blood forms showed transient parasitemias but survived
infection.
Effects of specific and non-specific immunization on the
course of infection with T. cruzi
Mice were injected ip with various combinations of
BCG and live attenuated T. cruzi prior to challenge with
5 LDgQ doses of virulent T. cruzi.

The challenge was given

8 days after the last immunizing dose.

An unimmunized

control group was infected with the same dose at the
same time.
Effects of iv immunization with BCG on the course of
infection with T. cruzi
Mice were given one or two doses of BCG (0.2 ml of a
Klett 100 preparation) iv 11 days and 1 day prior to
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infection.

Groups of mice treated in this way were then

challenged with 2 or 50

doses of T. cruzi.

Separate

groups of unimmunized control mice were infected with
either of the 2 doses of trypanosomes.

In addition, a

group of mice receiving only a primary dose of BCG, 11 days
before infection, was challenged with 2 LD^Q doses of
T. cruzi.

Deaths were recorded daily.

Effects of immunization with live and killed culture forms
on the course of infection with virulent T. cruzi
Live attenuated culture forms were administered as
described previously.

Killed parasites were prepared by

subjecting washed culture forms to 5 cycles of alternate
freeze-thawing, using an acetone-dry ice bath and a 37 C
water bath.

The organisms were counted before the freeze-

thaw treatment, and equivalent numbers of killed and live
parasites were used for the immunizations.

All injections

were given ip.
Effect of Treatment with Silicon Dioxide Particles on the
Course of Infection with T. cruzi
Silicon dioxide (SiOg) ("Min-U-Sil, Whittaker, Clark
and Daniels, N.Y. 5 p) were suspended in sterile phosphatebuffered saline (PBS) at concentrations of 100, 200, and
300 mg/ml.

Two-tenths of one of the suspension were in

jected ip into the various groups of mice.

Groups of 8
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mice each were given one of these doses on the day before
challenge, the day of challenge, or on both days.

A control

group receiving no Si02 was challenged at the same time
in a similar manner.

Deaths were recorded daily.

Course of Infection with T. cruzi
Reticuloendothelial clearance of colloidal carbon particles
in mice infected with T. cruzi (after Stuart, (88))
A solution of colloidal carbon was prepared as follows;
black ink, "Spezialtusche" (Gunther Wagner, Pelikan Werke,
Hanover, Germany), in a stock solution of 64 mg carbon/ml
was diluted in saline to a final concentration of 16 mg/ml.
The diluting saline contained approximately 0.5% concentra
tion of gelatin.

Normal mice and mice acutely ill with

Chagas' disease were injected iv with the carbon suspen
sion using doses of 100 mg/kg body weight.

The infected

animals had received 1 LDr. dose of virulent T. cruzi
50
—
16 days prior to administration of the carbon. Blood
samples of approximately 0.05 ml were taken from the retroorbital sinus with a heparinized capillary pipette at
intervals of 2, 6, 10 and 20 minutes after injection of
the carbon suspension.

The size of the blood sample was

constant at each bleeding.

The blood was mixed with 2.0 ml

distilled water immediately after being drawn and the
optical density of the suspension was read in a Coleman Jr.
II, Model 6/35 spectrophotometer at a wavelength of
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490 nm.

Control readings of blood alone from normal arid

infected mice were also made.
Changes in spleen weight during the course of infection
with ,T. cruzi
Spleens were removed from groups of mice, 5 mice/group,
at various days after ip injection of 1 x 103 blood forms
of T. cruzi and placed in a beaker containing MEM.
The spleens were trimmed of foreign tissue, blotted
dry, and weighed on à top-loading Mettler balance.

The

weights of each group of spleens were averaged.
Changes in total blood cell count during the course of
infection with T. cruzi
The blood of groups of five mice was pooled with a
small amount (0.5 ml) of heparinized saline at intervals
of 5, 8, 10, 12, 14 and 16 days after infection with
1 X 10^ virulent T. cruzi.

The total number of red blood

cells for each group and for an uninfected control group
were determined with a hemocytometer.
Similar procedures were used to compare total and
differential white blood cell counts.
Course of parasitemia during infection with T. cruzi
Male Swiss mice were inoculated ip with 1 LD^Q dose
of T. cruzi blood forms.

Groups of mice were exsanguin

ated every other day following infection, their blood was
pooled, and parasite counts were made with a hemocytometer.
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Effect of infection with T. cruzi on the inflammatory
response
Groups of 5 normal mice and of mice infected for
16 days with 1 LD^g dose of T. cruzi blood forms received
0.05 ml of a 1:5 mixture of turpentine in olive oil subcutaneously (sc) in the right ear and 0.05 ml of saline in
the left.

Difference in thickness between the ears were

measured with a "Schnelltaster" dial guage micrometer
after 24 h.
Tests for Delayed Hypersensitivity (DH) in
Normal Mice and Mice Infected with T. cruzi
Oxazolone (4-ethoxymethylene-2-phenyl oxazolone, BDH
Chemicals, Ltd. Poole, England), a potent skin-sensitizing
agent, and complete Freund's adjuvant (CFA) were used to
compare DH responses in normal and infected mice.
Oxazolone
One-tenth ml of a freshly prepared 3% (wt/vol) solu
tion of oxazolone in absolute ethanol was rubbed on the
pre-shaven abdomen of mice.

Seven days after sensitiza

tion, 1 drop (from a 25 ga. needle) of a 1.5% solution of
oxazolone in a 1:1 mixture of absolute ethanol and olive
oil was applied to the inner surface of each ear.

The

thickness of each ear was measured with a "Schnelltaster"
immediately before applying the solution and again at 24 h.
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CFA (Complete Freund's Adjuvant)
Two parts of Arlacel A (Sigma, St. Louis) and 3 mg
of dried tubercle bacilli were ground together with mortar
and pestle.
mixed.

Eight parts light mineral oil were added and

Ten parts sterile saline, pH 7.0, were added drop-

wise and an even emulsion was obtained.

The preparation

was drawn back and forth between two 10 ml syringes joined
with a double-hubbed needle.

Mice were injected sc with

0.2 ml of this preparation, which contained 0.1 mg of
dried tubercle bacilli.
Fourteen days after immunization with CFA, mice were
inoculated sc with 12.5 pg of BCG protoplasm suspended in
0.05 ml saline in one footpad.

The other footpad was

injected with the same volume of saline.

After 24 h, the

thickness of each footpad was measured with a "Schnelltaster" and the differences in measurements were recorded.
The response was expressed as the thickness of the foot
pad injected with the protoplasm minus that of the foot
pad injected with saline only.
Mice were sensitized with 1 of these antigens at
various times before or during injection and subsequently
skin tested.

The responses were compared to those of

uninfected animals.
The ability of mice to either develop or express
sensitivity to oxazolone was tested.

To determine the
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effect of trypanosome infection on the afferent arm of
the reaction, oxazolone was administered to mice at various
intervals after infection and the animals were subsequently
skin tested for delayed hypersensitivity.

To determine

the effect of infection on the efferent arm of the re
sponse, the animals were first sensitized with oxazolone,
and after sensitivity was attained the mice were infected
with 1

dose of T. cruzi. The infected animals and
50
—
an uninfected control group were then skin tested as before
at various intervals.

The results were expressed as the

percentage of the second reaction as compared to the first.
Tests for Humoral Responses in Normal Mice
and Mice Infected with T. cruzi
Two antigens, sheep red blood cells (SRBC) and
alkaline-detoxified bacterial lipopolysaccharide (dLPS),
were used to test the humoral response in normal and
infected mice.
SRBC (Sheep Red Blood Cells)
Whole sheep blood was obtained from the Rocky
Mountain Laboratory, Hamilton, Montana.

The blood was

centrifuged at 2000 x g for 5 minutes and the packed
layer of red cells retained.

These were washed three

times in sterile phosphate-buffered saline (PBS), pH 7.2,
O
and adjusted to a concentration of 2 x 10 red cells/ml,
or 4

n

X

10/0.2 ml.

Groups of 6 mice each were given iv
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injections of 0.2 ml of a freshly-prepared suspension of
SRBC at various days after infection with 1 LD50 dose of
T. cruzi blood forms.

The animals were exsanguinated

4 days later and their sera pooled.

Groups of mice were

bled on days 6,8, 10, 14 and 16 post infection.
An uninfected, unsensitized control group was handled
similarly.

The sera was frozen and inactivated at 56 C

for 30 minutes prior to testing.

The sera was tested

for antibodies by passive hemagglutination, using a 1%
solution of normal SRBC for the antigen.
dLPS (detoxified lipopolysaccharide)
The dLPS was obtained from Dr. Jon A. Rudbach,
Department of Microbiology, University of Montana, Missoula,
Montana.

Ten pg of dLPS, suspended in sterile PBS,

pH 7.0, was administered in 0.2 ml volumes.

The same

experimental procedure was used as in the assays for
antibodies against SRBC.

For the antigen in the passive

hemagglutination assay, SRBC with adsorbed dLPS were used.
Effects of Infection with T. cruzi on the
Development of Lymphoblasts in Local
Lymph Nodes Following Exposure to Oxazolone
At various days after infection with 1 LD50 dose of
T. cruzi, groups of 4 mice each received 3 drops (from
a 25 ga needle) of 3% oxazolone in absolute ethanol on
the inner surface of each ear.

The solution was rubbed
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into the skin with a cotton applicator stick.

Four

days later the auricular lymph nodes were removed from
each side of the animal's neck.

Nodes were removed 10,

12, 14 and 16 days post infection, as well as from an
uninfected control group which had received thé same
oxazolone treatment.

Immediately after excision, the nodes

were put in Plutznik's fixative and stored until all nodes
for the experiment were obtained.
the fixative was 24 h.

The minimum time in

The nodes were then embedded in

paraffin and sectioned with a Spencer Model F20 microtome
(7 microns).

The sections were mounted and stained with

methyl-green pyronin, a RNA stain.

The slides were

examined microscopically and the percentage of pyroninophilic (RNA-rich) cells, termed lymphoblasts, was determined.
The lymphoblasts in the nodes from sensitized, infected
mice were compared to those in the nodes of sensitized,
uninfected mice.

As a control, nodes from normal mice

were observed as well as nodes from infected unsensitized mice.
Transfer of Contact Sensitivity
In this and the other cell-transfer studies, C57B1/10
adult male mice were used.

Groups of 6 mice each were

sensitized with oxazolone on the abdominal region as
described previously.

Seven days later, they were
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killed by cervical dislocation.

Their spleens were

removed and forced through a fine wire mesh into petri
plates containing tissue culture media.

To avoid formation

of clots by spleen cells, no more than 2 or 3 spleens
were combined in the same petri dish, in approximately
20 ml of media.

The number of spleens combined was

largely a function of spleen size.

Animals infected for

12 or more days with virulent T. cruzi generally have
greatly enlarged spleens.

The cells were allowed to

settle in a 40 ml centrifuge tube to remove large particles.
The cell suspension was poured off, and centrifuged at
250 X g for 5 minutes, resuspended in media, and washed
2 times.

The cells were counted using Turk's solution to

lyse red blood cells and were adjusted to a concentra
tion of 2.5 X 10^ white blood cells/ml.

Recipient mice

were injected ip with 0.02 ml of this suspension (a total
of 5 X 10^ cells/recipient).

Twenty-four h after receiving

cells, the recipient animals were skin tested with oxazolone by applying 1.5%oxazolone in ETOH:olive oil to
1 ear and diluent only to the other ear.

This procedure

was followed in infected sensitized and uninfected
sensitized donor mice.

Infected sensitized donors were

used at 8, 10, 14, 16 and 17 days post infection.

To

assay for oxazolone response in the donors, they were
skin tested 24 h before being killed.

The oxazolone
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response was compared in groups of recipient mice,
5 mice/group, receiving cells from different groups
of donors.
Transfer of contact sensitivity with separate lymphocyte
populations
Mice were sensitized with oxazolone as described
earlier, and their spleens removed 7 days later.. The
spleen cells were separated by forcing the spleen through
a wire mesh as before.

The cells were then separated

into populations of B and T lymphocytes as described by
Hoades

, (40), using a nylon wool column.

Twelve spleens were removed and divided into tubes
containing 40 ml MEM with 2 spleens per tube.

The

erythrocytes were lysed in ammonium chloride and the
remaining cells were washed 3 times with MEM.

One and

seven-tenths g of nylon wool (FT-242, Fenwal Laboratories,
Morton Grove, 111) which had been prewashed in glassdistilled water was packed into the barrel of a 30 ml
disposable syringe to the 18 ml mark and autoclaved.
Before cell application, the nylon in the column was
saturated and rinsed with MEM containing 10% fetal calf
serum (MEM-FCS), and the column was incubated for 1 h at
37 C.

After this preincubation, 1.6 x 10^ cells, in 15 ml

warmed MEM-FCS were added to the column, and the prepara
tion incubated at 37 C in a humidified air-5% CO2 incubator.
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After the incubation the non-adherent cells were removed
by adding warmed MEM-FCS to the column, the first 30 ml
of effluent, the T-cell enriched fraction, was collected.
The column was washed with 100 ml warmed MEM-FCS and this
wash was discarded.

Adherent cells were removed by com

pressing the nylon wool with the syringe plunger, removing
the plunger and teasing up the wool with sterile forceps.
The wool was resaturated with MEM-FCS and compressed again.
The process was repeated until about 50 ml containing
the B-cell enriched fraction were collected.
Cell surface immunoglobulin as a B-cell marker was
identified by fluorescein-conjugated rabbit antimouse
immunoglobulin.

Fluorescent cells were identified as

B-cells and non-fluorescent cells as T-cells.
Transfer of normal mouse peritoneal exudate cells prior to
skin testing mice sensitized with oxazolone and infected
with T. cruzi
Mice were sensitized with 3% oxazolone 8 days after
infection with 1 LD__ dose of virulent T. cruzi. Seven
50
—
days following sensitization (15 days after infection)
the mice received 2 x 10^ peritoneal exudate cells from
normal donor mice and were skin tested immediately.

An

infected, sensitized control group received no cells, and
a group of normal, unsensitized mice received the same
dose of peritoneal exudate cells prepared as follows:
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Normal mice were killed by cervical dislocation.

A length

wise incision was made with a sharp scissors from the groin
to the chest, taking caution to avoid puncture of the peri
toneal membrane.

Five ml of cold tissue culture media was

injected with a 26 ga needle into the peritoneal cavity.
The distended abdomen was massaged for about 30 seconds
and the media was then withdrawn with a 20 ga needle,
taking care to keep blood from the exudate suspension.
The exudate suspension was put in cold siliconized glass
centrifuge tubes and centrifuged at 250 x g for 5 minutes.
The white blood cells were counted and resuspended in
O
MEM to a concentration of 1 x 10 cells/ml.
Attempts to transfer sensitivity to oxazolone to normal
and infected mice
Spleen cells were harvested as before from groups
of 7 mice/group which had been previously sensitized
and skin tested with oxazolone.

The cells were washed,

placed in a plastic petri dish and incubated for 30
minutes.

The non-adherent cells were removed by spray

ing the dish with media from a syringe and were again
incubated on a plastic surface.

The non-adherent

cells were removed and adjusted to a concentration of
2 X 10^ cells/ml and 0.02 ml of this suspension was in
jected into mice ip.

The recipient animals consisted of

normal mice and of mice that had been infected with
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1 LDgg dose of virulent T. cruzi 15 days previously.
Twenty-four h after receiving the spleen cells, the
animals were skin tested with oxazolone, and the results
were read after another 24 h.

As a control, normal spleen

cells, handled in the same manner, were injected into
other groups of normal and infected animals.

There were

5 recipient mice/group.
Effects of LPS on Mice Infected with T. cruzi
On various days following ip challenge with 1 LDgg
dose of virulent T. cruzi, different groups of Swiss
mice were injected iv with 1.0, 0.5, or 0.1 pg LPS
(J. A. Rudbach, University of Montana).

Mice were given

LPS on days 9, 12, 14, 16 and 18 days after infection.
Deaths within 12 h after LPS injection were quantified
and used for comparative data.
Statistics
The Mann-Whitney test was used to analyze the data.

Chapter 3
RESULTS
Determination of the LP
of the
Tulahuen Strain of T. cruzi in RML Mice
Mice consistantly died about 18 days following
infection with 1 x 10^ blood forms of T. cruzi.

The

average time of death was less predictable when lower doses
were used, so 1 x 10
ing dose.

parasites were chosen as the challeng

This provided the longest working period after

infection within a predictable course of infection.
Challenge with only 10-20 parasites would often kill mice
by 30 days or more, but survivors were often noted when
low challenge doses were used.

Route of infection was

found to make little difference; iv and sc challenge pro
duced similar results.

C57B1 mice were found to approximate

the Swiss mice in their susceptibility.

In all cases,

males were more susceptible than females, and young animals
were more susceptible than older ones (Fig. 1).
Immunization Studies
Effects of immunization with BCG and/or live attenuated
T. cruzi on the course of infection in mice challenged
with virulent T. cruzi
Mice were protected against lethal challenge with
blood forms of T. cruzi by ip inoculation of one dose of
attenuated T. cruzi given 18 days prior to challenge or by
35

Fig. 1.

Determination of the LDg^ in RI4L mice.

were six weeks old, and injected ip.
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two doses of the same preparation give 18 and 7 days prior
to challenge (Table 1).

A single inoculation of the

attenuated organisms given 7 days before challenge did
not give good protection.

Immunization with BCG gave

little or no protection, although some protection was noted
in mice receiving BCG 40 and 18 days before challenge.
A loss of effectiveness of protection due to specific
immunization was noted in mice immunized with both attenuated
T. cruzi and BCG.

Good protection was apparent in mice

receiving 1 or 2 doses of attenuated trypanosomes (groups
6 and 8) but animals were not completely protected by the
same treatment if they had been previously immunized with
BCG (groups 2,3,4,5,7).

This was true in all cases except

that in which mice were treated with 2 doses of BCG and 2
doses of attenuated trypanosomes.
Effects of BCG immunization iv on the course of infection
with T. cruzi
Mice immunized iv with BCG 1 and 11 days prior to
challenge with 50

doses of T. cruzi survived signifi

cantly longer than did normal mice, although 7 of 8 were
dead by the 19th day of infection (Table 2).

Mice

challenged with 2 LD^Q doses showed a similar trend,
although the differences were not significant.

Very little

difference in survival time was seen between groups
receiving 1 or 2 doses of BCG.
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Table 1. Effects of Immunization with BCG and Attenuated
Trypanosoma cruzi Trypomastigotes on the Survival Time of
Mice Infected with Virulent T. cruzi.a
Group

Immunizations
d-40b d-lgc ^ ^
d-7^
.
BCG® BCG ATC
ATC

Number
Dead/Total

Survival Times
(days)
x
Range

1

+

+

+

0/8

2

+

+

+

2/8

16.0

15-17

+

+

2/8

28.5

17-30

+

+

4/8

20.5

17-26

26.3

17-38

20.0

17-26

6/8

28.0

17-32

3

+

4
5

+

+

3/8

6

+

+

0/8

7

+

4/8

8

+

0/8

9
10

+

8/8

17.9

16-30

11

+

5/8

20.2

19-25

8/8

17.8

16-20

12

a challenged with 5 x 10
(5 LD^Q doses) ip

virulent blood forms

^ 40 days prior to challenge
^ 18 days prior to challenge
^

7 days prior to challenge

® Paris strain; approx. 1 x 10^ viable organisms/dose
f attenuated live T. cruzi culture forms; approx.
1 x 10°/dose ip
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Table 2. Effects of iv Immunization with BCG on the
Survival Time of Mice Challenged with Virulent
Trypanosoma cruzi.
Group

BCG
Number No. Dead/ Survival Times
Immunizations^
Challenge
Total
(days)
d-lic d-11, d-lG
doses"
Range
X

1

+

2

-

3

-

4
5

+

+

50

7/8

16.2

13-19

50

8/8

13.4

13-15

2

8/8

20.3

17-30

2

8/8

17.2

16-20

2

8/8

20.3

17-27

^ Paris strain of BCG; approx.
1 X 10 viable organisms/dose
^ No. LD50 doses of virulent blood forms, ip
^ 1 injection of BCG 11 days before challenge
^ 2 injections of BCG 11 and 1 days before challenge
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Effects of immunization with live and killed culture forms
on the course of infection with virulent T. cruzi
All mice given 2 x 10^ live attenuated T. cruzi 20
days prior to challenge survived infection, regardless of
the route of immunization (Table 3).

Killed culture forms

offered little protection with any of the immunizing methods.
employed.
Effect of Treatment with Silicon Dioxide Particles on the
Course of Infection with T. cruzi
Mice receiving 2 doses of silica, at any of the
concentrations used, died significantly faster when infected
with T. cruzi than did infected control mice (Table 4).

The

mice treated with a single dose of 10 or 40 mg of silica
also differed significantly from the controls in their
survival times.

The group treated with one 20 mg dose did

not differ significantly from controls in survival time.
There were 4 survivors in this group, as compared to 2 in
the group given one 40 mg dose of silica, and 1 in the
control group.
Course of Infection with T. cruzi
Reticuloendothelial clearance of colloidal carbon particles
in mice infected with T. cruzi
Mice infected with T. cruzi (16 days after receiving
1 LD
dose) were able to remove colloidal carbon from
50
their bloodstream significantly faster than normal animals
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Table 3. Effects of Immunization with Live or Killed
Attenuated Trypanosoma cruzi on the Survival Time of Mice
Challenged with Virulent Trypanosoma cruzi.
Group Immunization^ Days Before No. Dead/ Survival Times
Challenge^
Total
(days)
% Range
1

L, iv^

20

0/8

— —

2

L, ip^

20

0/8

——

3

K, ivG

20

5/8

21.0

18-26

4

K, ip

20

4/8

20.5

19-22

8/8

18.3

17-19

5

— —

^ approx. 2 x 10^ attenuated T. cruzi, live or killed
per dose
^ approx. 2 x 10^ virulent blood forms (2 LD^Q doses),
ip injection
^ live T. cruzi, iv injection
^ live T. cruzi, ip injection
0
T. cruzi killed by freeze-thaw method
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Table 4. Effects of Treatment with Silica on the Survival
Time of Mice Infected with Virulent Trypanosoma cruzi.^
Group Dose Silica Treatment^ No. Dead/
Survival
p
Total
Times (days) <0.05
d-1 d 0 d-l,d 0
Range
%
1

lOmg

2

II

3

II

4

20mg

5

II

6

II

7

40mg

8

II

9

II

10

none

+

—

-

+

-

+

—

-

+

-

8/8

18.0

15-20

+

8/8

18.3

17-20

+

+

8/8

17.8

16-20

+•

—

5/8

18.6

16-26

-

7/8

20.7

18-26

-

+

8/8

17.8

16-20

+

—

7/8

17.4

16-19

+

7/8

17.4

16-19

+

—

4-

—

-

+

-

—

+

8/8

17.5

16-19

-

—

—

7/8

19.7

16-21

^ all mice challenged ip with 1 x 10^ T. cruzi blood
forms
^ silica particles given ip the day before challenge
(d-1), the day of challenge (d 0), or on both days
(d-1, d 0)
^ p value for Mann-Whitney significance test; level
of significance when compared to control group (10)
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(Fig. 2, Table 5).

Control readings of blood from normal

and infected mice were approximately the same, indicating
that the presence of trypanosomes in the blood samples did
not alter the results.
Changes in spleen weights during the course of infection
with T. cruzi
Individual spleen weights increased dramatically as
the infection progressed (Fig. 3, Table 6).

This increase

in the weights of individual spleens was apparent 8 days
after infection was induced.
Changes in total blood cell count during the course of
infection with T. cruzi
Total erythrocyte and leukocyte counts were lower in
acutely infected mice than in normal mice.

Erythrocyte

numbers delined from 11-12 x lO^/ml to about 6 x 10^/ml
as the infection approached the terminal stage.

Leukopenia

was also noted; the total white cell counts decreased from
2-3 X 10^/ml to 0.9-1.4 x 10^/ml.

There was no apparent

selective decline of a single leukocyte population (Fig. 4&5).
Course of parasitemia during infection with T. cruzi
(Fig. 6, Table 7)
The number of circulating trypanosomes rose logrithmically following ip injection of 1

dose of T. cruzi.

Eighteen days after infection, parasite levels ranged from
6-20 X 10^/ml blood.
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Table 5. Reticuloendothelial Clearance of Colloidal
Carbon in Mice Infected with Trypanosoma cruzi.
Time (minutes)
Injection

% Transmittance^
Normal Infected^

p ^0.05^

'2

16.2

30.2

+

6

17.8

30.6

+

10

20.2

29.8

+

20

21.2

32.4

+

^ infected with 1 x 10^ virulent blood forms
T. cruzi ip 16 days prior to carbon injection
^ average value for 5 mice; % transmittance
spectrophotometrically
^ p value for Mann-Whitney significance test,
comparing normal group to infected group

Fig. 2.

Reticuloendothelial clearance of colloidal

carbon in mice infected with T. cruzi.
16 days after infection with 1 x 10

Mice were tested

blood forms.

Clear

ance was determined by evaluating blood withdrawn at
intervals for spectrophotometric transmittance.
Symbols:

infected mice—
normal mice.

% TRANSMITTANCE (AVERAGE READING FOR GROUP
OF 5 MICE)

Table 6. Changes in Spleen Weight During the Course
of Infection with Trypanosoma cruzi.
No. Days
Infected^

Ave. Spleen Wt. (g)^
0.12

2

0.12

4

0.13

6

0.17

8

0.28

10

0.54

12

0.55

14

0.68

16

0.68

18

0.74

^ infection with 1 LD
dose of
T. cruzi blood forms ip
^ average value of 5 mice

Fig. 3.

Changes in spleen weights during the course

of infection.
forms.

Mice were infected ip with 1 x 10^ blood

AVERAGE WEIGHT (GRAMS)

Fig. 4.

Changes in blood cell numbers in mice infected

with T. cruzi.
blood forms.
averaged.

Mice were infected ip with 1 x 10

Cell counts for groups of 5 mice each were

N represents the average value for uninfected

male RML mice, 6 weeks of age.
Symbols:

leukocyte counts
erythrocyte counts

—

NUMBER OF LEUKOCYTES X 1 0

NUMBER OF ERYTHRECYTES X 1 0

Fig. 5.

Differential leukocyte counts during the course

of infection with T. cruzi in RML mice. Mice were infected ip with 1 x 103 blood forms. N represents the
average value for uninfected mice.
Symbols;

neutrophils
lymphocytes
monocytes
eosinophils

——

% OF TOTAL LEUKOCYTE NUMBER
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Table 7. Course of Parasitemia During
Infection with Trypanosoma cruzi.
No. Days
Infected^

No. Trypanosomes/
ml Blood

8

6

X

10^

10

2

X

10^

12

6

X

10^

14

5

X

105

16

3

X

10®

18

4

X

10®

^ infected with 1 x 10^ virulent
blood forms of T. cruzi ip

Fig. 6.

Course of parasitemia during infection with

T. cruzi.
forms.

Mice were infected ip with 1 x 10^ blood
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5 X 10

1 X 10

5 X 10'

Q
O
O
_J
PQ

1 X 10'

2
4
T 5 X 10
(/)

F 1 X LO''
o
W
3
G 5 X 1 0 (TOO FEW
TO COUNT)
10

14

TIME AFTER INFECTION (DAYS)

18

20
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Effect of infection with T. cruzi on the inflammatory
response
Significant differences in ear thickness were seen
between infected and control mice 24 h after injection of
a turpentine:olive oil mixture.

The mice treated with

cortisone developed a lowered inflammatory response.

It

was less than those of the other 2 groups of animals tested;
and cortisone-treated mice showed a more rapid regression
of inflammation than did normal animals (Table 8).
Tests for Delayed Hypersensitivity (DH) in
Normal Mice and Mice Infected with T. cruzi
CFA
Groups of 8 mice each were infected with T. cruzi
either 4 days before, on the same day, 4 days after or
9 days after sensitization.

The animals were subsequently

tested for delayed hypersensitivity 14 days after sensiti
zation.

Thus the mice were tested 5, 10, 14 or 18 days

after infection with T. cruzi.

As shown in Fig. 7, mice

tested on days 5 and 10 after infection had delayed
hypersensitivity reactions roughly equivalent to those of
uninfected mice.

Those tested 14 or 18 days after infection

had markedly decreased delayed responses.

These 2 groups

differed significantly from the uninfected mice.
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Table 8. Effects of Infection with Trypanosoma
cruzi on the Inflammatory Response in Mice.
a
Inflammatory Response (mm)

d
p <^0.05

Group

Treatment

1

none

0.42

-

2

T. cruzi^

0.32

+

3

cortisone^

0.25

+

^ 0.05 ml of a 1:5 mixture of turpentine:olive oil was
injected in one ear; 0.05 ml saline was injected into
the other. Difference between thickness of the 2 ears
was recorded 24 h later.
^ 1 X 10^ blood forms injected ip 16 days prior to test
^ hydrocortisone acetate, 50 mg/kg, given ip 24h prior
to test
^ Mann-Whitney significance test used to analyze the
data compared to normal control (group 1)

Fig. 7.

Suppression of delayed hypersensitivity to

12.5 vg BCG protoplasm injected into the footpad of
mice immunized with BCG and infected with T. cruzi.
Each point represents the mean response of 8 mice, skin
tested 14 days after sensitization with CFA.
Symbols:

infected mice
normal mice

MEAN FOOTPAD THICKNESS (MM)
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Oxazolone
Influence of infection with T. cruzi on the induction of
delayed hypersensitivity.

In the experiment shown in

Fig. 8, groups of mice were sensitized with oxazolone on
days 0, 4, 8 and 10 after infection with T. cruzi and tested
for sensitivity to oxazolone 8 days after sensitization
(8, 12, 16 and 18 days after infection).

Mice sensitized

with oxazolone on the day of infection displayed delayed
hypersensitivity to oxazolone when tested 8 days later,
whereas animals given oxazolone on the fourth day after
infection and tested 12 days after infection showed a
marked decrease in the response.

The response to oxazolone

was further decreased in mice sensitized 8 and 10 days
after infection and tested 16 and 18 days after infection,
respectively.

The 3 latter groups of infected animals

differed significantly in their response from the uninfected
controls.
Influence of infection with T. cruzi on the expression of
delayed hypersensitivity.

A rise in response to oxazolone

was noted in uninfected mice as the time following the
first skin test increased (Fig. 9).

However, infected

mice that had been sensitive to oxazolone before infection
became less responsive as the infection progressed.

This

loss of sensitivity was first apparent by the fourteenth day

Fig. 8.

Suppression of delayed hypersensitivity to

oxazolone applied to the ears of mice sensitized with
oxazolone and infected with T. cruzi.

Each point repre

sents the mean response at 8 days after sensitization
with oxazolone.
Symbols

infected mice
normal mice

MEAN EAR THICKNESS (MM)

Fig. 9.

Decreased ability of mice infected with T. cruzi

to express delayed hypersensitivity to oxazolone.
point represents the mean response of 8 mice.

All mice

were sensitive to oxazolone prior to infection.
Symbols;

infected mice
normal mice

Each

MEAN EAR THICKNESS (% OF INITIAL RESPONSE)
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after infection.

Again, the 3 groups of mice infected

the longest (14, 16 and 18 days) differed significantly
in their responses from the uninfected mice.
Effects of immunization with attenuated T. cruzi on delayed
hypersensitivity to oxazolone.

Mice immunized with 2

doses of live attenuated T. cruzi 14 and 7 days prior to
challenge with virulent trypanosomes developed greater
sensitivity than did unimmunized animals (Fig. 10).

Both

groups of mice were infected 8 days prior to sensitization
with oxazolone and tested for DH 16 days after infection.
Mice immunized with the attenuated trypanosomes showed
consistently higher levels of sensitivity to oxazolone
than did normal mice.

This state of increased responsive

ness occurred in both challenged and unchallenged mice.
The responses differed significantly only between the
sensitized, infected animals and the other groups.
The cellular response in auricular lymph nodes of normal
and infected mice sensitized with oxazolone.

The medullary

areas of the auricular lymph nodes from normal mice
sensitized 3-4 days earlier by applying oxazolone to the
ear showed a large number of lymphoblasts.

These are large,

pyroninophilic cells easily distinguished from unstimulated
cells.

Auricular nodes taken from unsensitized mice that

had been infected with T. cruzi, 1 LD^Q dose for 16 days.

Fig. 10.

Effects of immunization with attenuated T. cruzi

on delayed hypersensitivity to oxazolone in mice infected
with T. cruzi.
of 8 mice.

Each bar represents the mean response
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also had high numbers of large, pyroninophilic cells.
However, in these animals, the occurance of these cells
was noted in both the medullary and cortical areas.

The

nodes from infected animals are also enlarged, as are those
from normal sensitized animals, due to the generalized
adenopathy resulting from infection.
The nodes from infected, sensitized mice had a propor
tionally higher content of lymphoblasts than those from
infected, unsensitized mice.

These differences were

apparent in the medulla, but the cortical areas showed
little difference in the number of lymphoblasts (p. 71).
Transfer of Contact Sensitivity
Delayed hypersensitivity to oxazolone is readily
transferrable between inbred mice (Table 9).

Spleen

cells were used in these studies, although better results
may be often obtained using peritoneal exudate cells.
Fewer cells are required if peritoneal exudate cells are
used, and a 24 h delay from the time of transfer to the
time of skin test is not necessary.
Lymphocyte populations were separated from spleens
removed from mice sensitized 7 days earlier with oxazolone.
The lymphocytes were divided into B-cell enriched and T-cell
enriched populations by passage through a nylon wool column.
Groups of syngeneic recipient mice received equal numbers
of cells from either the T-cell or B-cell fraction or a
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Table 9.
Spleen Cell Transfer of Contact Sensitivity
from Infected to Uninfected C57B1/10 Mice.
Number of Days
Donors^ Infected

Donor
Response (mm)b
X ± SD

Recipient
Response (mm)^
X ± SD

p^

0

0.60 ± 0.10

0.50 ± 0.07

>0.05

10

0.55 ± 0.10

0.45 ± 0.10

>0.05

14

0.28 ± 0.09

0.42 ± 0.11

£0.01

16

0.05 ± 0.05

0.40 ± 0.09

<0.01

17

0.05 ± 0.05

0.44 ± 0.12

<0.01

^ sensitized with oxazolone 7 days before cell
transfer
^ oxazolone skin test immediately before transfer
^ oxazolone applied at 24 h and skin tested at 48 h
after receiving 3 x lO^ spleen cells from infected,
sensitized donors
^ p value from Mann-Whitney significance test;
donor vs. recipient
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comparable number of a 50-50 mixture of the 2 fractions.
The T-cell fraction was significantly more effective in
transferring contact sensitivity than was the B-cell
fraction.

The mixture was intermediate in effectiveness.

Spleen cells from infected, sensitized donors were
able to confer specific sensitivity upon normal recipients,
regardless of the stage of infection of the donors.

Sensi

tized mice that were unable to respond to eliciting doses
of oxazolone possessed spleen cells capable of conferring
sensitivity to oxazolone as effectively as cells of unin
fected animals.

No significant differences were seen in

the responses of the recipient animals when donor cells
from normal mice or mice at different stages of infection
were used.

(Table 10)

Transfer of normal mouse peritoneal exudate cells to mice
sensitized with oxazolone and infected with T. cruzi
Mice infected 15 days previously with 1 LD^Q dose of
T. cruzi and sensitized to oxazolone on the eighth day
following infection were given peritoneal exudate cells
iv from normal mice immediately before skin testing on the
fifteenth day.

These mice were able to respond to oxazo

lone significantly better than infected, sensitized mice
which did not receive peritoneal cells (Table 11).
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Table 10. Transfer of Contact Sensitivity in C57B1/10
Mice with Separated Spleen Cell Populations.
Population of
Cells Received

Response (mm)
of Recipients
% ± SD

Statistical Analysis
Groups Compared p ^0.05®

b'^

0.21 ± 0.06

B vs. B + T

+

B + T^

0.38 ± 0.12

T vs. B + T

+

T^

0.46 ± 0.12

T vs. B

+

none

0.10 ± 0.02

^ 5 recipients/group, 1.25 x 10 cells/recipient;
skin tested with oxazolone (1.5%) 24 h after
cell transfer, read 48 h after cell transfer
^ B-cell enriched; shown to be approx. 95% B-cells
by immunofluorescence
^ 50% B-cell fraction and 50% T-cell fraction
T-cell enriched; shown to be approx. 80% T-cells
by immunofluorescence
® Mann-Whitney significance test applied
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Table 11. Restoration of Skin Test Response to Oxazolone
by Transfer of Normal Peritoneal Exudate Cells to Mice
Sensitized with Oxazolone and Infected with T. cruzi.
Treatment

Response (mm)

p^

X ± SD
Peritoneal Exudate Cells^

0.28 ± 0.08

None

0.04 ± 0.05

£0.01

^ 2 X 10^ cells given iv at time of application of
skin test dose of oxazolone
^ the Mann-Whitney test was used to analyze the data
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Transfer of spleen cells from mice sensitized with
oxazolone to normal mice and infected mice
Mice infected for 16 days with 1 LD_. dose of T. cruzi
50
—
responded significantly less to eliciting doses of oxazo
lone than did normal mice following transfer of spleen
cells from uninfected sensitized donors (Table 12).
Lymph node cell transfer of contact sensitivity from
infected to uninfected mice
Auricular lymph nodes from normal and infected mice
which had been sensitized by application of oxazolone to
both ears 3 days before, were removed and transferred to
normal recipients.

This experiment was done to ensure

that sensitization was carried out during the stages of
high parasitemia and greatest immunosuppression.

Both

infected and uninfected mice transferred contact sensitivity
to normal recipients.

No significant difference was ob

served between the two groups of recipients (Table 13).
Effects of LPS iv on Mice Infected with T. cruzi
Normal Swiss mice inoculated iv with 1.0, 0.5 or
0.1 pg of LPS displayed no visable effects (Table 14).
However, many of the infected mice inoculated with the
same amount of LPS died shortly after administration of
this material.

Deaths due to inoculation with LPS were

first noted 9 days after the mice were infected with 1
LD_„ dose o f T. cruzi, and became more frequent a s the
50
—
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Table 12. Spleen Cell Transfer of Contact Sensitivity
to Infected and Uninfected C57B1/10 Mice.
Skin test Response (mm)
JT ± SD

p*^

Donors^

0.60 ± 0.10

Recipients''^
infected

0.22 ± 0.05

<0.01

Recipients'
uninfected

0.47 ± 0.06

<0.01

Infected Control

0.05 ± 0.05

<0.01

^ uninfected mice sensitized with oxazolone 7 days before
'oxazolone applied 24 h and skin tested 48 h after
receiving 3 x 10^ spleen cells from sensitized
donors
peak parasitemia stage, 16 days following
ip injection of 1 LD^g dose
^ data analyzed with Mann-Whitney significance
test; comparisons made to donor values. The
recipient groups also differed significantly from
each other at the 0.01 level.
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Table 13. Lymph Node Cell Transfer of Contact Sensitivity
from Infected to Uninfected C57B1/10 Mice.
No. of Days Donors^
Infected

Recipient Response
x ± SD

0

0.30 ± 0.08

16^

0.26 ± 0.10

p^

>0.05

oxazolone (2%) applied to both ears three days
prior to removal of auricular lymph nodes and
cell transfer (5 mice/group)
^ p value from Mann-Whitney significance test
comparing recipient groups
C

1

infected with 1 x 10 blood forms ip 16 days
before cell transfer of 5 x 10® lymphocytes
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Table 14. Increased Susceptibility to Endotoxin
in Mice Infected with Trypanosoma cruzi.
Number of Days Infected at
Time of Endotoxin Administration

Number of Deaths/Total
Following iv Injection
of Endotoxin
0.Ipg

0.Syg

1. Oyg

6

0/4

0/4

0/4

9

0/4

2/4

0/4

12

0/4

2/4

2/4

14

1/4

2/4

1/4

16

2/4

4/4

4/4

18

4/4

4/4

4/4
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infection progressed.

Deaths were usually directly

proportional to the number of days the animals had been
infected and the amount of LPS administered.
Humoral Responses to SRBC and dLPS
Mice showed a decreased ability to produce antibodies
against both SRBC and dLPS as the infection progressed
(Fig. 11).

Decreased production of antibodies against dLPS

was first noted on the fourteenth day after infection, and
was most marked just before death.

On the other hand,

antibodies against SRBC were not decreased until late in
the course of infection.
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Illus. 5.

Ear, normal mouse,

hematoxylin and eosin (H & E)

224X.
Illus. 6.

Ear, normal mouse sensitized to oxazolone.

Mouse sensitized to oxazolone 8 days and skin tested
1 day prior to removal of ear.
of monocytic cells.
Illus. 7.

Note extensive infiltration

H & E 224X.

Ear, infected mouse sensitized to oxazolone.

Mouse infected ip with 1 x 10^ blood forms 16 days prior to
removal of ear.
above.

Mouse was sensitized andskin tested as

H & E 224X.

Illus. 8.

Ear, infected mouse sensitized to oxazolone,

with macrophages administered prior to skin test (Table 11).
H & E 224X.
Illus. 9.

Ear, oxazolone sensitized, monocyte infiltration.

Typical cells of the sensitized ear.

H & E 1400X.
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Chapter 4
DISCUSSION
The results presented in this study demonstrate a
number of interesting aspects of the immune responses
occurring in mice with acute Chagas' disease.

The informa

tion can be divided into two main areas: 1) studies on
resistance to T. cruzi infection in the mouse, and 2) ef
fects of acute infection on the immune responses of the
mouse.

Since T. cruzi is an intracellular parasite, in

fections with this organism provide an informative model
for study of host-parasite interactions on a cellular
level.

In addition, the presence of virulent T. cruzi in

a susceptible host affects the host's ability to mount an
immune response to antigens unrelated to those of the para
site.

Thus, studies of T. cruzi infection can be used to

obtain specific knowledge of the immune system as well as
specific information on the host-parasite relationship in
this particular disease.
Immunization Studies
Both specific and non-specific immunization proce
dures were used in attempts to protect mice against vir
ulent challenge with T. cruzi.

Mice were immunized with

live attenuated Mycobacterium bovis (BCG), a non-specific

stimulator of the cellular immune response, or with
86
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preparations of either live attenuated or killed at
tenuated T. cruzi.

The parasites are attenuated by re

peated passage in culture.

These organisms are viable

when introduced, but are not able to produce disease or
persistent infection in mice.
Since the Tulahuen strain of T. cruzi is an intra
cellular parasite preferring cells of the reticuloendo
thelial system, it appeared likely that BCG, which ac
tivates phagocytic cells, might be useful for protecting
mice against the intracellular trypanosomes.

However,

all reports (69) but one have indicated that this is not
the case.

In the present study, as in most others, BCG

was of little or no value in protecting mice against
virulent challenge with T. cruzi.

This appears to be a

rather unusual situation, for BCG has been proven suc
cessful in protecting against a wide variety of intra
cellular parasites, including many viruses and bacteria,
as well as Leishmania (86) and Plasmodium (13) infections.
It is apparent that the route of immunization in
fluences the effectiveness of BCG as a protecting agent.
Clark et

(13) have reported successful immunization

with BCG only if administered iv for protection of ex
perimental animals against malaria.

Similarly, Ortiz-

Ortiz (19) reported successful immunization utilizing iv
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administration of BCG prior to challenge of mice with
virulent T. cruzi.

In the present study, an attempt to

repeat this experiment was less successful than that re
ported by Ortiz-Ortiz et. a]^.

This may be due to differ

ences in virulence of the strain used.

However, in the

present study, mice receiving iv treatment with BCG did
survive significantly longer than unimmunized controls,
although all but one of the immunized mice died from the
parasitic infection.

Kuhn et al. (54) have reported

complete lack of protection against challenge with the
virulent Brazilian strain in mice pretreated with high
doses (3 mg wet weight) of BCG iv.

In Kuhn's experiments,

similar numbers of trypanosomes were used for challenge
as in the experiments reported here.
In contrast to the slight degree of protection seen
in mice immunized with BCG iv, none was seen in mice
which received BCG ip.

This is in agreement with the

results reported by Hoff (42) who found that macrophages
from mice injected ip with BCG were able to destroy the
trypanosomes ^ vitro, but that protection was not seen.
Hoff suggests that, although BCG may non-specifically
activate macrophages to increase their phagocytic and
cytolytic capabilities, specific stimulation may be
required

vivo to produce a population of lympho

cytes directed against the parasites.
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Mackaness (58) has shown that specific immunological
mechanisms may activate macrophages, but once they are
activated they show an increased ability to engulf and
kill organisms unrelated antigenically to the original
immunogen.

Organisms such as BCG, Corynebacterium parvum,

or Listeria monocytogenes are known to non-specifically
activate macrophages (2, 35, 87).

Animals stimulated

immunologically by these agents are more resistant to
infection with many bacteria, viruses, and tumors.

Treat

ment of mice with C. parvum has been shown to be effective
in protecting them against malaria infections, even when
the immunizing organisms were first killed (68).
The only proven method of obtaining consistent pro
tection against T. cruzi is by injection of specific
T. cruzi antigen, preferably in the form of live avirulent
organisms.

In addition to attenuated culture forms

shown to be effective in this study, avirulent strains
obtained from non-human hosts may be used (42).

Parasites

treated with irradiation and, more recently, those killed
with sodium perchlorate have been shown to be of protec
tive value (48, 49).

It should be remembered that studies

of this type may not always be reliable due to the
tremendous variation in the virulence of parasites in any
given host species.
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In this study, it was repeatedly demonstrated that
treatment of mice with one or two doses of attenuated
culture forms rendered mice resistant to challenge with
one

dose of virulent trypanosomes, provided that

the antigen was given sufficiently ahead of challenge
(Table 1).

Mice given this treatment 18 days prior to

challenge were completely protected, but were not if given
the antigen only seven days before challenge.

It is

suggested that cell-mediated immunity is involved in this
protection.

Culture forms killed by freeze-thawing failed

to confer protection (Table 3).

With the single exception

noted above, nearly all attempts to immunize mice with
killed trypanosomes have been unsuccessful.

In general,

cell-mediated immunity is best produced by administering
a preparation of live, attenuated organisms as opposed to
killed preparations.

Even though the attenuated trypano

somes do not persist after introduction into mice, they
cause a slight and transient parasitemia, and provide a
more prolonged antigenic stimulation.

A similar effect

may be achieved by the use of certain adjuvants combined
with specific trypanosome antigen (44), but killed prep
arations alone are generally ineffective.
An interesting aspect of the immunization experi
ments was the observation that mice treated with BCG
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prior to the administration of live culture forms were not
completely protected against virulent challenge.

In con

trast to this, mice which were not first treated with BCG
were always protected after immunization with live culture
forms.

This phenomenon has since been verified by

Kiersenbaum (48) who found that mice pre-treated with
C. parvum were not completely protected by a preparation
of T. cruzi antigen proven effective in normal mice.

It

may be that non-specific activation of macrophages is
not a useful procedure for increasing

vivo killing of

T. cruzi, and, in fact, may even be deleterious.

As

pointed out previously, Hoff (42) has found non-specifically activated macrophages to be more effective ^ vitro
in destroying T. cruzi.

However, in our laboratory we

have seen consistently that mice immunized with BCG are
not protected against challenge with T. cruzi, and often
die more rapidly.

It might be postulated that, in_ vivo,

macrophages are capable of taking up the parasite, but
cannot destroy it.

Since the organism is an intracellular

one, activated macrophages may simply be more accommodat
ing in providing an environment in which the parasites
can divide.

This argument is not supported by the

vitro

studies, which show that the activated macrophages are
capable of killing the parasites after ingestion.

Perhaps
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in vivo other factors are important.

One possible ex

planation might be directed toward the T-cell population,
with the postulation of a group of suppressor T-cells.
Such cells are seen in animals with tumors or immunodepressed aged animals (82).

However, evidence for their

presence in this instance is quite weak, especially in
view of all the instances in which BCG provides non
specific protection.

It may be simply that macrophages

can more easily engulf parasites in an ^ vitro situation,
perhaps due to artificially concentrating the phagocytes
on a plastic surface enabling them to trap and break
down the parasite more effectively.
A decrease in the ability of the attenuated trypanosomes to protect mice immunized previously with BCG may
be explained on the basis of reticuloendothelial stimula
tion by the BCG.

Perhaps administration of BCG stimu

lates the macrophages to kill and degrade the immunizing
trypanosomes.

This could prevent production of specific

cell-mediated immunity by the attenuated trypanosomes
since they may not persist as long in the BCG-stimulated
host.
The effects of treating mice with BCG and attenuated
trypanosomes can be seen in Table 1.

Of the groups of

mice that received both organisms, only those mice in
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group one, which had two injections of each preparation,
survived totally.

It appears that in this case, the effect

of two doses of trypanosomes overcame any adverse effect
due to the BCG.

The only other groups in which all sur

vived were those that received only attenuated trypano
somes, either 18 or 18 and 7 days beofre challenge.

A

single immunizing dose of trypanosomes given less than
12-14 days prior to challenge is not effective in providing
complete protection.' Groups of mice that received immu
nizing doses of trypanosomes sufficiently ahead of challenge,
but which were previously treated with BCG, showed only
about 50 per cent survival.

BCG alone, given ip, did not

significantly increase numbers of survivors or survival
time, although two doses were consistently more effective
than one.

When BCG was given iv, somewhat better results

were obtained as far as increasing survival time.

Mice

given two iv injections of BCG 11 and 1 day prior to
challenge survived significantly longer than their unimmunized counterparts (Table 2).

This was consistent

when challenge was with either two or fifty LDgg doses.
In addition, a single iv injection of BCG given 11 days
before challenge increased survival time significantly.
These results indicate that non-specifically activated
macrophages may be able to confer at least partial
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protection.

Perhaps iv administration of the BCG allows

for better contact of the organisms with the phagocytic
cells of the liver, spleen and lungs, the most important
organs of the reticuloendothelial system.

Activation of

cells in these areas may be useful against the circulat
ing blood forms, providing increased contact between
activated host cells and the parasite.

It should be

noted, however, that increased survival time does not
always indicate protection.

The mice treated with BCG

nearly all died, averaging about eight days longer sur
vival than the unimmunized groups.
Not only was a live vaccine preparation found to be
effective in producing immunity, but, as indicated pre
viously, a minimum time of 12 to 14 days was necessary
between immunization and challenge for the preparation to
be effective.

This time period corresponds to that re

quired for macrophage activation following a primary
stimulus (70).

In most experiments a single immunizing

dose protected as effectively as two.
Further evidence of the importance of the macro
phage in producing resistance was seen in experiments in
which silicon dioxide, a macrophage toxin, was used in
conjunction with infection with T. cruzi.

The results

generally agreed with those obtained by Kiersenbaum et al.
(47) who found that depression of reticuloendothelial
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activity by silica resulted in decreased resistance to
infection with T. cruzi.

In addition, these workers

reported that stimulation of the reticuloendothelial
system (RES) by diethylstilbesterol before infection
reduced both mortality rates and levels of parasitemia.
An interesting situation exists in this system,
since the Tulahuen strain of T. cruzi multiplies within
macrophages.

It might therefore be expected that selec

tive killing of macrophages prior to infection could
actually lead to a lowered parasitemia by decreasing the
number of available cells in which the parasites can
divide.

Initially we believed this was the case, since

there were often more survivors in those groups receiving
the highest doses of silica.

However, repeated experi

mentation with varying doses of silica and timesof ad
ministration proved these instances to be isolated and
inconsistent in occurrence.

Overall, the data indicated

a significantly longer survival time in the untreated
mice.
Some of the inconsistencies observed with macrophage
activation studies and resistance of animals to T. cruzi
infection may be due to the preference of many strains
for cells of the RES.

Studies of macrophage activation

with BCG may be complicated by the involvement of two
intracellular organisms trying to inhabit the same
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population of cells.

Data using non-living RES activators

and depressors may be more useful in determining the roles
of the RES in resistance against T. cruzi infection.
Kuhn and Durum (53) have shown with adoptive transfer
experiments that the onset of the ability of mice infected
with T. cruzi to transfer immune protection via lympho
cytes occurs about nine days after infection.

Recipients

of spleen cells from infected donors were resistant to
subsequent challenge given three hours after the cells.
It was noted that high parasitemias did not correlate
with survival times, since the passively immunized mice
survived infection but developed high parasite levels.
This immunity appears to differ from that actively con
ferred with attenuated trypanosomes as described in these
experiments, for high parasitemias did not develop
following challenge of actively immunized mice.
To explain their observations, Kuhn and Durum (53)
postulated the presence of a specific antibody response
to a particular product of the trypanosome that may be
important in immunity.

Koeberle (51) has postulated

that trypanosomes invade cells by secreting a lytic enzyme.
An antibody to such a product was suggested by Kuhn and
Durum to explain the disparity between high parasitemias
and survival of adoptively immunized mice.

They reasoned

that circulating antibody to such a factor could limit
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cell invasion and cause an accumulation of parasites in
the blood, resulting in "increased longevity and an
increase in parasitemia in these immune manipulated mice."
They suggested that increased longevity could be due to
decreased tissue damage since fewer cells are invaded
and destroyed.

The weakness of this argument, aside from

the fact that no such lytic product or antibody to such
a product has been found, is that T. cruzi has never been
observed to multiply outside of host cells.

Since Kuhn

and Durum observed an increase of over 100 fold in the
number of parasites from the challenge dose to the peak
of parasitemia, cell invasion apparently occurs.

Also,

there has been consistent failure in attempts to transfer
protection with serum from infected animals.

In summary,

there have been a number of indications that parasitemia
levels are not good indices of pathological state.

There

apparently is more than the activated macrophage involved
in the immune status of the experimental animal, since
the phagocytes would seemingly tend to decrease the numbers
of extracellular forms rather than to allow them to increase.
However, in the present study involving protection with
live, attenuated organisms, specifically activated macro
phages probably play a very important role in protection.
High numbers of parasites did not develop in immunized
mice, and macrophages from acutely ill animals were observed
to appear activated when cultured ^ vitro.
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This observation indicates that the RES may be stimu
lated during acute Chagas' disease.

Peritoneal exudate

cells removed from mice 15 days after infection with one
LD^Q

dose appeared larger than peritoneal exudate cells

from normal animals, with more and larger pseudopodia
(personal observation).

Infected mice show an increased

ability to clear colloidal carbon from the blood stream
(Fig. 1, Table 5).

Similar reports have been made by

Clinton e_t a2. (15).

Associating increased carbon clear

ance with an increase in the activity of individual
phagocytes may not be entirely correct.

This study

shows that a dramatic increase in spleen size occurs in
infected animals, beginning on about day seven or eight
after infection with one

dose (Fig. 2, Table 6).

Increased carbon clearance could be merely a function of
the relatively huge spleen possessed by these mice.

The

rate of carbon clearance and course of changes in spleen
size in immunized, infected animals is not known.

This

information might be very useful in interpreting the mode
of action of the live trypanosome vaccine.
Of possible significance along these lines are the
observations by Grogan (33) that treating animals with
anti-thymocyte serum (ATS) did not decrease their phago
cytic activity as measured by carbon clearance.

This

indicates that immunosuppressed animals can show normal
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abilities to phagocytose, a situation somewhat analogous
to that existing in mice acutely infected with T. cruzi.
Immunosuppression in Experimental
Chagas' Disease
Studies were undertaken to determine the effects of
acute infection with T. cruzi on the immune response of
mice to antigens unrelated to those of the parasite.

It

was found that acute parasitemia was accompanied by pro^
nounced alterations in the immune responses of the un
protected host.

In all cases, there were direct correla

tions between the degree of parasitemia and the degree of
immunosuppression.

Responses in mice to various antigens

were found to be decreased as the infection progressed.
Various physical changes that accompanied the infection
were also studied.
Within eight days following ip challenge with one
LDgQ dose of virulent trypanosomes, the organisms could
be seen in the peripheral circulation.

After that time,

the numbers rose logarithmically until death of the host
on about the eighteenth day following infection (Fig. 3,
Table 7).

Accompanying this rise in parasitemia was a

corresponding increase in spleen size (Fig. 2, Table 6).
Alterations in blood counts were noted in mice as
the infection progresses.
twelfth day of infection.

Marked anemia occurred by the
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Leucopenia was noted by the sixteenth day after
infection.

Differential counts indicated that the major

populations of white blood cells were depressed, without
one population being severely depleted over the others.
This would correspond to the observations of Taliaferro
and Pizzi (90) who noted lymphocyte depletion in the
spleen.

It does not appear that the observed immuno

suppression can be wholly attributed to lymphocyte deple
tion, especially since infected animals have been shown
to mount a good immune response against T. cruzi antigens
(99).

Also, a good inflammatory response was produced in

infected mice following application of an alive oilturpentine mixture (Table 8).

Measurable induration and

erythema appeared in normal and acutely infected mice
by 24 hours after application of the irritant.

This

suggests that the observed suppression of response to
certain antigens involves a rather specific mechanism
directed against cells of the immune system rather than a
non-specific depression of white blood cell populations.
The slightly lowered inflammatory response in infected
animals is probably due to the decrease in circulating
leukocytes that accompanies infection.
Mice showed a decrease in their primary response to
SRBC and LPS during the terminal stages of infection when
parasitemia was at its peak.

The antibody levels were
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measured by passive hemagglutination procedures.

It would

probably have been better to use a more sensitive method
such as assaying for numbers of plaque-forming cells, so
that sharper distinctions between antibody levels could
have been made.
Depression of the immune response to heterologous
erythrocytes has been noted before in animals with para
sitic infections.

Clinton (15) observed a depression of

antibody to burro erythrocytes in mice during the acute
stages of infection with a "myo- and reticulotropic strain
of T. cruzi."

Numbers of plaque-forming cells were

assayed during the primary response to the erythrocytes.
Their results closely paralleled those obtained in this
study.

In both studies, it was found that infected mice

not given erythrocytes had negligible amounts of non
specific agglutinins in their serum.
Perhaps the parasitic disease most often associated
with immunosuppression is malaria.

Wedderburn (103)

observed a reduced number of hemolytic plaque-forming
cells in the spleens of mice infected with Plasmodium
berghei yoelli and given SRBC.

These animals were in

fected with a non-pathogenic Plasmodium that produces a
high parasitemia but is a self-limiting disease.

It is

probable that a different mechanism is at work in this
system than in acute Chagas' disease, a rapidly fatal
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infection.

Also, the malaria parasite infects red blood

cells rather than cells of the reticuloendothelial
system.

However, like Chagas' disease, the peak of

immunosuppression corresponds to the peak of parasitemia.
Malarial-induced immunosuppression has been demon
strated using a variety of antigens including heterolo
gous RBC (5, 29, 30, 77, 83), human gamma globulin (29),
Salmonella typhimurium (45), and certain viruses (77).
However, responses to human serum albumin, Keyhole limpet
hemocyanin (KLH), and bacteriophage ^ x 174 are reportedly
normal in mice with malarial infections (5, 29, 30, 101).
These results indicate that responses to T-cell
independent antigens are normal, while those to T-cell
dependent antigens are depressed.

Presumably, many of

the T-cell independent antigens, such as bacteriophage,
KLH, and LPS, do not require macrophage processing or
T-cell cooperation for antibodies to be produced.

In con

trast, T-cell dependent antigens, such as erythrocytes, do
require macrophage processing and T-cell-B-cell interaction
for the production of antibodies.

These findings concern

ing malarial immunosuppression suggest a defective immune
mechanism at the T-cell or macrophage level.

Further, it

has been noted that P. berghei infection has no suppress
ive effect on an already established response to SRBC,
and that malarial antibodies are produced at the time of
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maximal immunosuppression.

These findings suggest that

there is not a non-specific inhibition of immunoglobulin
synthesis (29, 30).
No other reports of the effects of infection with
T. cruzi on antibody response to T-cell independent anti
gens are available.

This study indicates that the re

sponse to dLPS, an antigen not requiring T-cell processing
(102), is depressed during infection.

Here again it would

be of interest to perform more sensitive tests for anti
body levels.
Although decreasedresponse to SRBC may indicate a
T-cell or macrophage involvement, a reduced response to
dLPS cannot be explained in these terms.

It does not

seem likely that a decrease in immunoglobulin synthesis
occurs since trypanosomal antibodies are produced during
acute infection.

However, lymphocyte depletion in the

spleen and lymph nodes does occur.

Perhaps this prevents

de novo immunoglobulin synthesis to an antigen administered
when the trypanosomal antigen is already present in high
amounts.
An interesting observation was made by Perkins and
Makinodan (71) who have shown ^ vitro that an excess of
macrophages has an inhibitory effect on the SRBC response.
Presumably, increased macrophage activity removes the
antigen making it less accessible to the lymphocyte
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populations.

However, it would seem that increased

uptake of antigen processing by macrophages is required
for antibody production against erythrocytes.

Never

theless, consistent observations associate increased
macrophage activity with decreased antibody production.
As mentioned earlier, mice with acute T. cruzi infec
tion appear to have activated macrophages. Perhaps
increased phagocytosis of parasites affects antibody
production to SRBC in infected mice.

However, such an

explanation is not sufficient to explain a decreased
response to dLPS if macrophage processing is not re
quired by plasma cells to produce antibodies against
endotoxin.
This study demonstrates that a significant depression
of the cellular immune response develops in mice suffer
ing from acute infection with T. cruzi.

Groups of mice

were immunized with CFA and challenged with T. cruzi
on the same day or on the fourth or ninth day after
immunization.

Animals tested five days after infection

responded as well as did the normal sensitized mice but
animals tested 14 days after infection with T. cruzi
had markedly reduced delayed hypersensitivity reactions.
Animals sensitized with CFA on the fourth day after
infection and tested on the eighteenth day of infection
failed to express delayed hypersensitivity.

It is
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evident that as the disease progresses the animals have
less ability to express delayed hypersensitivity.
Studies of induction of delayed hypersensitivity
to oxazolone in mice infected with T. cruzi appeared
to indicate an inability to develop a delayed response
as the disease progressed.

This interpretation may be

incorrect, however, since the tests for delayed hyper
sensitivity were performed at least eight days after
the animals were sensitized.

This prevented sensitiza

tion past the tenth day of the eighteen day duration
of the disease.

The disease had progressed to a marked

extent by the time of skin test in the animals sensitized
four or eight days after infection.
Animals sensitized with oxazolone, skin tested, and
infected two days later, were skin tested again at various
days after infection.

By the twelfth or fourteenth day

of infection the animals were unable to express a delayed
response.

These data indicate that the efferent rather

than the afferent arm of the response is suppressed.
Immunosuppression during acute Chagas' disease has
been previously reported.

Clinton et

(15) observed

a lowered antibody response to burro erythrocytes in
mice infected with a "myo- and reticulo-tropic strain"
of T. cruzi.

Observations made by these workers, also

supported by our own observations, indicated that
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an increased phagocytic and cytolytic activity of macro
phages occurred in infected animals.
Many other protozoal infections are associated
with immunosuppressive effects.

Mansfield and Wallace

(59) noted a decreased response to CFA in rabbits chron
ically infected with T. congolense.

The rabbits were

immunized with CFA after infection in these experiments.
Decreased antibody production to sheep red blood cells
Occurred in mice infected with Plasmodium berghei yoelii
(29), but their response to oxazolone was not affected,
even during peak parasitemia.

In this instance, mice

develop an acute but non fatal disease.

Other workers

have observed immunosuppression in malarial infections
(31, 77), including depression of certain antibody
responses in children with malaria.

A diminished anti

body response to ovalbumin in hamsters infected with
Leishmania donovani has been observed by Clinton et aJL (14).
Inasmuch as oxazolone sensitivity is an indicator
of a cell-mediated response (4, 96, 97), the failure of
animals to respond to eliciting doses of this substance
indicates an involvement of the macrophage and/or the
thymus-dependent lymphocyte populations.

The histological

appearance of contact sensitivity reactions is character
ized by an abundance of these cell types (97).

Spleen

damage and lymphocyte depletion is found in mice infected
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with T. cruzi (90, 92) and depressed lymphoid cell popu
lations have been reported in animals with Toxoplasma
gondii infections (39, 43).

Thus lymphocyte depletion

may be thé key to the observed immunosuppressive effects
in acute Chagas' disease.

However, if it is the efferent

arm of the response that is depressed, as these results
indicate, alteration of macrophage function may be re
sponsible for immunosuppression.
The Tulahuen strain of T. cruzi is reticulotropic,
showing a preference for macrophages as the host cell.
Although the macrophage may be functioning normally in
phagocytosis (15), harboring the parasite might in some
way interfere with the receptor sites on the cell surface
that interact with T-lymphocytes in cellular responses.
The T-lymphocyte itself may be the key to the immuno
suppressive effects, since this cell is involved in
cellular responses and is required for production of
antibodies to erythrocytes.

However, a similar argument

may be made for implicating the macrophage as the primary
cell involved.

Infection of the macrophage may affect

the macrophage-T-cell interaction, or might interfere
with processing of the test antigen by the macrophage.
Although the response to oxazolone in mice acutely
infected with malaria is not depressed, there is evidence
that cell-mediated immunity may be depressed in such
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animals.

Sengers ^ aj.. , (83), observed that infected

mice were unable to develop cell-mediated immunity
against a skin heterograft.

Observations of this type of

immunosuppression in malaria is rare, however.

It seems

that there are different mechanisms involved in malarial
and American trypanosomal-induced immunosuppression.
Loose et al. (56) has called malarial immunosuppression
a macrophage mediated defect.

This suggestion is based on

the observation that macrophages from infected mice showed
decreased capability to invoke antibody formation when
transferred to syngeneic recipients.

The macrophages

were first allowed to phagocytose heterologous erythro
cytes ^ vitro, then passed to normal and infected re
cipients.

Macrophages from mice with malaria were appar

ently less effective at processing and/or presenting the
antigen for the production of an immune response.

The

authors concluded that malaria was immunosuppressive
through action on the macrophage by interfering with anti
gen processing.

This would indicate that the inductive

phase of the immune response is interrupted, in that the
T-cells are not stimulated by macrophage-associated antigen.
To determine whether the depressed cellular response
during T. cruzi infection was directed toward the induction
or expression of delayed hypersensitivity, several experi
ments were done using oxazolone as the test antigen.
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Oxazolone is a hapten that binds to epithelial proteins
to become antigenic.

It invokes a good cell-mediated

response when applied to the skin and is convenient for
rapid sensitization and easy elicitation.
Administration of oxazolone to the skin produces
rapid proliferation of lymphocytes in draining lymph
nodes (97).

This process is part of the induction of a

cellular immune response.

Three to four days following

sensitization with oxazolone, draining lymph nodes contain
large numbers of lymphoblasts.
large cells, rich in RNA.

These are relatively

These cells are able to trans

fer sensitivity to oxazolone when injected into syngeneic
animals (4).

Several experiments were done in the present

study to determine whether lymphoblasts were formed
following oxazolone administration in an infected mouse.
Since formation of these lymphoblasts following antigenic
stimulation indicates the induction of an immune response,
their presence or absence in an infected animal would in
dicate whether or not this phase of the response was being
interfered with.
Quantification of lymphoblasts in sensitized infected
mice is difficult, since the infectious process alone leads
to adenopathy and increased numbers of large dividing
cells in the lymph nodes.

However, by comparing draining

lymph nodes from infected mice, both sensitized with
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oxazolone and unsensitized, it was found that there
were proportionally more lymphoblasts in the sensitized
animals.

Furthermore, cells from draining nodes of

sensitized infected mice were able to transfer contact
sensitivity to normal mice (Table 13).
It is also of interest to note that in infected
animals not sensitized with oxazolone, lymphoblast^like
cells appear in both the cortical and paracortical
regions.

However in mice sensitized with oxazolone, the

paracortical areas and not the cortex show large numbers
of lymphoblasts.

This observation made it easier to

assess the induction of contact sensitivity in infected
mice.

The results obtained from histological observations

and cell transfer studies indicate that induction of
contact sensitivity does occur in infected mice, as
measured by the ability of lymphocytes to become sensi
tized following administration of oxazolone.

No experi

ments of this nature have been reported in association
with immunosuppression in other diseases.

It would be

of interest to determine whether induction of the immune
response occurs in other parasitic diseases that lead to
immunosuppression.
To further examine whether the afferent or efferent
arm of the immune response was interfered with, a series
of cell transfer studies was undertaken.
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A primary criterion for the existence of cellmediated immunity is whether or not the immunity or sensi
tivity can be passively transfered with sensitized T-lymphocytes.

To demonstrate the nature of the response to oxazo-

lone, transfers of different populations of lymphocytes
from sensitized to normal mice were made (Table 10).

By

using a nylon wool column, spleen cells from sensitized
mice were divided into three groups; a B-cell enriched
population, a T-cell enriched population, and a mixture
of the two.

Macrophages are nearly all eliminated from

the preparation by the nylon column.

The three prepara

tions were injected into syngeneic recipients which were
skin tested 48 hours later and read 24 hours after skin
test.

The results confirmed the cell-mediated nature of

the response to oxazolone.

The T-cell enriched populations

transferred sensitivity much more effectively than the
B-cell

enriched populations.

Asherson & Ptak (4) showed that contact sensitivity
was more effectively transferred with peritoneal exudate
cells than with lymph node cells, although both types
were effective.

This observation has been confirmed in

our laboratory.

This is probably due to the presence of

large numbers of macrophages in the peritoneal cell prep
arations.

The macrophages are already primed to the

oxazolone, so when they are transferred along with sensi
tized T-cells, all the requirements for expressing a
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delayed hypersensitivity response are met.

If only the

lymphocytes are transferred, it is best to wait 24 to
48 hours before skin testing to allow the sensitized
T-cells to interact with the recipient's macrophages.
It cannot be reasonably argued that this delay produces
active sensitization rather than passive transfer, for at
least four to five days are required to bring about
active sensitization to oxazolone (97)
Contact sensitivity was readily transferred from
infected to normal mice, even though the infected animals
were unable to respond to the agent.

The sensitivity

was successfully transferred even when the donor mice
were in the final days of infection, at the height of
immunosuppression.

These experiments indicate that the

infected mice, although unable to respond to oxazolone,
have sensitized T-cells.
One shortcoming of the spleen cell transfer experi
ments results from the limited number of days animals
can be sensitized with oxazolone following infection.
Since the mice usually die by eighteen days after infection,
and because about six days are required to obtain sensi
tized spleen cells following oxazolone application, it
is not possible to sensitize animals in this manner when
they are in the peak infection period.

Oxazolone must be

applied to the abdomen by-the eleventh or twelfth day
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after infection to allow the spleen cells to become
sensitized before the mice succumb.

As seen earlier,

the peak period of immunosuppression occurs between days
14-18.
To overcome this problem, the experiment mentioned
earlier was performed.

Mice were sensitized by apply

ing oxazolone to both ears during the period of peak
parasitemia (Table 13).

The successful transfer of

sensitivity with lymph node cells indicates that mice
are able to become sensitized to oxazolone during the
height of immunosuppression.
Based on these observations, it was postulated that
the immunosuppression might be due to a macrophage defect.
The first approach to examine this possibility was to
administer normal peritoneal exudate cells, which had
been adhered to glass, to infected sensitized mice immedi
ately before applying the eliciting dose of oxazolone to
the ear.

The addition of normal macrophages to infected

animals prior to skin testing improved their response
significantly.

This indicates that perhaps a deficiency

of available macrophages in the infected mice could explain
the immunosuppression.

Since there doesn't seem to be a

significant drop in any single circulating leukocyte
population during acute infection (Fig. 6), and there is
an increased clearance rate of colloidal carbon in infected
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mice (Table 5), a decrease in macrophage number is probably
not responsible.

However, the macrophages may be unable

to respond to an antigen such as oxazolone, possibly due
to the large numbers that are infected with parasites.
The presence of many parasites, both inside and outside
of macrophages, may interfere with the ability of the
macrophage to recognize and respond to another antigen.
Evidence against this possibility comes from the observa
tion that mice immunized with attenuated trypanosomes
and infected with virulent forms respond well to oxazolone
(Fig. 10).

This might provide an argument against antigenic

competition, since much antigen is present in the immunized,
infected mice.

However, extensive parasite invasion of

macrophages and high parasitemia does not occur when
specifically immunized mice are infected.

It could be

the intracellular presence of the virulent parasites that
is chiefly responsible for the failures of the immune
response to other antigens.
Potentiation of Bacterial Lipopolysaccharide (LPS)
Toxicity in Mice Infected with T. cruzi
When studying the antibody response to bacterial
LPS in infected mice, it was noted that many of the animals
died suddenly, often within fifteen minutes, after receiv
ing an iv injection of the endotoxin.

Subsequently,

detoxified endotoxin was used for antibody assays.

The
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degree to which the toxicity of LPS was potentiated was
quantitated in further experiments.
Mice in the acute stages of infection with T. cruzi
were found to die of what appeared to be toxemia or endo
toxin shock when given iv injections of very small amounts
of LPS.

Death generally occurred within twelve hours

or less after the mice received the endotoxin.

In mice

near the terminal stages of infection, deaths occurred
in one hour or less.

In general, mice infected the

longest were most susceptible to injection of endotoxin
(Table 14).

Whereas 200 pg or more are usually required

to kill a normal RML adult mouse (personal observation),
as little as 0.1 yg was toxic to acutely infected mice.
It is difficult to suggest a mechanism to explain
the potentiation of LPS toxicity, since the mode of action
of LPS is not clearly understood.

Filkens (23) observed

that sonicates of rat peritoneal, alveolar, and hepatic
macrophages detoxified endotoxin from Salmonella enteriditis,
and he suggested that macrophage lysosomes were important
in the detoxification of LPS.

Evans and Alexander (21)

have reported that endotoxin activates peritoneal exudate
cells so that they non-specifically kill target cells.
In addition, Gery and Waksman (24) haVe reported that
macrophages treated with endotoxin release a soluble
factor that stimulates T-lymphocytes.

It is apparent that
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LPS effects macrophages, which in turn can presumably
detoxify LPS.
Studies on the relationship between endotoxin and
the RES have indicated that the liver and spleen are the
major organs responsible for the removal of endotoxin
from the blood (20) and its subsequent detoxification
(94).

Stimulation of the RES by BCG or glucan has been

shown to increase sensitivity to endotoxin (18, 89).
In addition. Loose et a2., (55) found increased toxicity
of endotoxin in mice infected with Plasmodium berghei;
a 41-fold increase was reported.

They gave iv injections

of from 200-500 yg of endotoxin, much higher doses than
found necessary to kill mice infected with T. cruzi.
In malaria, as in T. cruzi infections, there appears
to be stimulation of the RES (16, 50). In the studies
of Loose et

(55) it was concluded that the ability

to detoxify LPS was reduced in infected mice.

Evidence

indicates that activation of the RES has an effect on the
lysosomes, preventing them from detoxifying the LPS.
This effect could be due to depletion of lysosomal contents
upon activation, possibly resulting from the presence of
intracellular parasites.
In view of the apparent stimulation of the RES
during T. cruzi infection, it seems more likely that
failure to detoxify endotoxin, rather than failure to
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phagocytose it might explain the increased susceptibility
to LPS at the macrophage level.

We have observed that

agents that block RES activity, such as colloidal carbon
and silica also potentiate LPS toxicity in mice.

Lysosomal

depletion could explain these situations as well.

Although

the RES is not activated by such agents, they act to fill
the phagocytes with particles, as with carbon, or to
rupture them, as with silica.

Both situations cause

release of lysosomal contents.
The presence of very large numbers of circulating
trypanosomes can deprive the host of a tremendous amount
of glucose.

The parasites are extremely active, and they

use serum glucose in their metabolism.

Several workers

have reported that blood glucose concentrations fall to
below a fasting level subsequent to administration of
endotoxin (84).

Cumulative effects of infection and

endotoxin could cause hypoglycemic shock.

Shands et al.

(84) tested for this by administering glucose to infected
animals, but they had variable results and were not able
to draw any definite conclusions.

Chapter 5
SUMMARY
Resistance to Trypanosoma cruzi in mice is cellmediated and requires specific activation of the immune
system.

Several lines of evidence support this hypo

thesis.

1) BCG alone does not protect against acute

infection.

2) Live preparations of attenuated trypano-

somes provide good protection whereas killed organisms
do not.

3) To obtain protection, live preparations

must be administered at least 12-14 days in advance of
challenge.

4) Administration of silica particles, a

macrophage toxin, prior to challenge exacerbates infection.
Activation of the immune system with BCG not only fails
to confer immunity to T. cruzi, but actually interferes
with induction of specific resistance by attenuated
trypanosomes.

Mice sensitized with BCG prior to immuni

zation with attenuated trypanosomes were not protected
by the immunization procedure as well as normal mice.
Although the phagocytic system is apparently activated
in mice infected with T. cr'uzi, and the inflammatory
response appears to be largely unaffected, the ability
of infected animals to mount a response against antigens
other than those of the trypanosome is decreased.

Mice

infected with T. cruzi and sensitized with heterologous
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erythrocytes at various intervals after infection lost
their ability to produce antibodies as the infection
progressed.

Similarly, there was a decrease in the

animals' response to detoxified bacterial lipopolysaccharide during the latter stages of infection.
The effect of acute infection on the cellular immune
response was also studied.

Mice were immunized with

either Freund's complete adjuvant or oxazolone, a chemi
cal sensitizing agent, and were subsequently skin tested
with either BCG protoplasm or oxazolone to detect delayed
hypersensitivity.

Depression of the response to these

antigens was observed in infected mice during the stage
of marked parasitemia.

Mice which were responsive to

oxazolone before infection lost their ability to respond
as the infection progressed.

When immunized with live

attenuated T. cruzi, mice developed a greater than normal
sensitivity to oxazolone and survived infection.

Infected

mice unable to respond to oxazolone were capable of
conferring sensitivity to this substance in normal
syngeneic mice via spleen cell transfer.

The ability of

infected mice to respond to oxazolone was significantly
improved when macrophages from normal syngeneic donors
were administered at the time of skin test.

When normal

and infected mice were used as recipients of lymphocytes
from syngeneic oxazolone-sensitized donors, the normal
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mice responded significantly better than did the infected
mice.

These results indicate that immunosuppression

due to infection with T. cruzi is directed toward expression
rather than induction of the cell-mediated immune response
to the antigens employed.
Decrease in the capability of the immune response
of infected mice was also shown by their increased sus
ceptibility to the toxic effects of bacterial lipopolysaccharide.

Mice became increasingly susceptible to

minute quantities of the toxin as the infection progressed,
leading to death shortly after administration of the
substance.
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APPENDIX
Bouin's fixative
Picric acid (saturated aqueous, filtered)

75 ml

Neutral formalin (filtered)
20 g sodium acetate plus 100 ml 4 0% formalin

25 ml

Glacial acetic acid

5 ml

Giemsa stain for mouse blood cells
Stock giemsa:

1.

Dissolve 0.5 g giemsa powder in 33 ml
glycerine.

2.

Heat at 55-60°C for 1 1/2 to 2 h.

3.

Add 33 ml absolute methanol.

0.15.M phosphate buffered saline pH 6.4 (PBS):
0.85% saline

100 ml

0.15 M Na^HPO^

32.2 ml

0.15 M KH2PO4

67.8 ml

1.

Fix smears in absolute methanol for 10 seconds or longer.

2.

Allow slides to air dry.

3.

Rinse a small test tube with 5 ml distilled water and
add another 5 ml distilled water to the tube. Add a
few crystals of hematoxylin to the test tube. If the
water appears yellow the pH must be adjusted. Add
about 0.1 ml 1% KCO3/200 ml distilled water. The color
of the water in the 5 ml tube should be light pink in
color when hematoxylin is added.

4.

Use 0.2 ml stock giemsa/ml PBS pH 6.4.
with 3 ml/slide for 30 seconds.

5.

FJpat off stain with adjusted distilled water.
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Flood smear
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Turk's white blood cell diluting fluid
Glacial acetic acid

2 ml

Aqueous gentian violet 1% w/v

1 ml

Distilled water
Mix and filter

100 ml

